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INTRODUCTION 
It is well established that immaturity of the lung is the primary 
etiologic factor predisposing to the development of the respiratory 
distress syndrome of the newborn, the major cause of death i~ premature 
infants. The overall maturity of the fetal lung has been found to de-
pend to a great extent on the maturity of the type II epithelial cells 
of the alveolus. These cells are the recognized source of lung sur-
factant, a surface tension lowering substance, rich in dipalmitoyl-
phospatidylcholine, which lines the alveolar space and prevents the 
collapse of the lung at expiration. The type II cells contain charac-
teristic lamellar inclusion bodies, the intracellular storage form of 
surfactant, as well as other secretory elements including rough endo-
plasmic reticulum, Golgi. apparatus and multivesicular bodies, the pre-
sumed precursors of lamellar inclusion bodies. 
I 
Previous studies have indicated that glucocorticoids, ard perhaps 
' 
other pharmacologic agents, promote fetal lung maturation by acceler-
ating the structural, functional and biochemical development of the 
alveolar· type II cells. Pilocarpine, a parasympathomimetic alkaloid, 
has been shown by previous studies to stimulate the secretion of sur-
factant by type II cells in the adult. There is little information 
available concerning the effects of pilocarpine on the surfactant sys-
tem of fetal animals. There is, however, some evidence that it is 
capable of causing increased secretion of surfactant in ·the later 
1 
stages of gestation. 
This study was designed to investigate the reactions of the de-
veloping fetal rabbit lung to multiple maternal doses of pilocarpine 
on successive days at a point in gestation when the surfactant system 
is just beginning to mature. These reactions include morphologically 
demonstrable changes in surfactant synthesis and secretion as well as 
changes in the maturation process of the fetal lung, such as changes 
in cell numbers or cell division. 
Ultrastructural studies constituted the main emphasis of this 
project and employed morphometric and stereologic analyses. These 
data are correlated with light microscopic morphometric analysis, 
a biochemical study and a new application of the rapid technique 
of scintillation autoradiography. 
2 
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LITERATURE REVIEW 
General Concepts of the Pulmonary Surfactant System 
A Swiss physician, Von Neergard (' 29), was the first t,o suggest 
that the surface tension of fluid in the alveoli of the lung might be 
lower than that of other body fluids, and that this might be due to the 
accumulation of surface active material. Studying pressure-volume re-
lationships in excised degassed pig and dog lungs filled with either 
fluid or air, he found that the transpulmonary pressures were lower for 
a given volume of fluid than air and concluded that 2/3 to 3/4 of the 
retractive pressure of the lung was due to surface forces. The theo-
retical significance of surface forces in the initial expansion of the 
lungs at birth was appreciated by Hilson and Farber ( '33) and Gruenwald 
('47). Surface properties of the lung were discussed by Radford et al. 
('54) in relation to the maintenance of alveolar stability an~ the de-
l 
! 
termination of respiratory surface area. 
A major contribution was made by Pattle ('55) who demonstrated 
that bubbles expressed from the lungs were very stable in air and had 
a high resistance to anti-foam agents. He concluded that these bubbles 
had a very low surface tension, ~ess than 0.06 dynes/em. Furthermore, 
low surface tension was found to be a unique property of these pulm-
onary bubbles since bubbles made of fluid from other sources, such as 
blood, showed no such stability and decreased rapidly in size when ex-
3 
4 
posed to air. Further studies supported his original conclusions that 
the surface tension of the lining film of the lungs was very close to 
zero ;(Pattle, '60, '65). In addition, he theorized that in the absence 
of extremely low surface tension, the alveolar "bubble of air" would 
collapse upon itself due to the law of Laplace (P= 2y /r, whe're P=inter-
nal pressure, y=surface tension and r=the radius of the alveolus) giv-
ing rise to massive atelectasis. 
Clements et al. ('57, '58) measured the surface tension lowering 
properties of lung extracts obtained by rinsing lungs with 0.09% sa-
line, mincing whole lungs in saline and squeezing material from the 
cut surfaces of lungs into saline. They found that, in vitro, as a 
film of this lung material was compressed, the surface tension dropped 
and, furthermore, that the changes in surface tension during compres-
sian and expansion of the film did not coincide. About the same time 
Mead et al. ('57) described static pressure-volume characteristics of 
! 
saline and air filled dog lungs. They found that in excised Jungs the 
\ 
\ 
surface forces were minimized by saline filling and consequently hyst-
eresis, or the difference between the curves on inflation and defla-
\ 
tion, was small. In air-filled lungs, however, hysteresis was marked 
and much like that observed by Clements and co-workers in films of lung 
extracts. 
It is now well established that the major function of pulmonary 
surfactant is the maintenance of alveolar stability. As the radius of 
the alveolus decreases, pulmonary surfactant reduces the surface ten-
sian at the air-liquid interface. If pulmonary surfactant were not 
5 
present, upon expiration there would be massive alveolar collapse, or 
atelectasis. Due to the action of surfactant in lowering the surface 
tension, a residual volume of air always remains in the lung (Avery and 
Said, '65). 
Other demonstrated or theorized physiologic functions of surfac-
tant, as reviewed by many authors including Avery and Mead ('59), 
Scarpelli ( '68) , Morgan (' 71) and Read ( '71) , may be summarized as 
follows. Alveolar liquid balance. It is thought that in the ~bsence 
of surfactant the increased surface tension in the alveoli would aug-
ment capillary hydrostatic pressure and result in transudation of fluid 
into the alveoli. This may occur in some pathologic conditions of the 
lung, resulting in massive pulmonary edema. Pulmonary capillary flow. 
The surface tension in the alveoli does rise during inflation of the 
lung, as shown in a typical hysteresis loop. This controlled rise in 
surface tension exerts a limited amount of force which does augment 
! 
I 
capillary pressure, as described above. This regulated force: aids in 
I 
overcoming gravity and "pulling" blood up to the apices of the lungs. 
Clearance of the alveolar space. Although this task is accomplished 
primarily by the alveolar macrophages, pulmonary surfactant does appear 
to play a role. Surfactant is cleared from the alveolar spaces, in 
part, by a central flow through tbe bronchiolar tree and trachea to the 
pharynx, along with the mucous sleeve of the airways. In so doing, 
debris which was trapped in the surfactant layer is carried along and 
thus cleared from the alveolar space. Reaction to infection. The al-
veolar surface layer has also been implicated as part of the body's de-
fense mechanism. This is thought to involve an antigen-antibody reac-
tion which localizes bacteria at the alveolar surface (Shifrine and 
Gom:;lay, '65). 
The presence of a fluid lining layer in the alveoli of mammalian 
lungs was first described morphologically by Terry ('26) and subse-
quently elaborated upon by him (Terry, '45). The significance of this 
lining layer was, for the most part, overlooked until the 1950's when 
the physiology of the surfactant system was being described. }1acklin 
('54, '55) provided the first strong morphologic evidence of an extra-
cellular lining layer in the alveoli. He observed that the alveoli 
were lined by an "exterior alveolar mucoid fluid" which had the stain-
ing characteristics of mucopolysaccharides. By phase contrast micro-
scopy, he observed "myelin figures" forming the layer, which he post-
ulated as consisting of either lecithin or cholesterol. His studies 
were followed by several reports dealing with the staining af.finities 
I 
' 
of the lining layer, all using light microscopy (Groniowsky apd 
I 
Biczyskowa, '69; Bernstein et al., '69; Kikkawa et al. , '70). 
Convincing electron microscopic demonstration of this alyeolar 
lining layer was for a time lacking, due to the difficulty in preserv-
6 
ing it during fixation. Weibel and Gil ('68) were the first to clearly 
show the ultrastructure of this layer. Their observations were con-
firmed by Kikkawa ('70), Kuhn ('72) and others. It is now well esta-
blished that the alveolar lining layer consists of two portions, the 
first being a mucinous coat which is an integral part of the alveolar 
epithelial cell membranes (Balis et al., '71). This is similar to 
7 
other such coats 'vhich exist on the surfaces of many cells and is dis-
tinct from the second part of the alveolar lining layer, the surfactant 
layer. This surfactant layer, in turn, consists of two portions, a 
base layer, or hypophase, which contains proteins and mucopolysaccha-
rides and a 4 nm thick superficial lamellar layer. This lamellar 
layer is thought to be a monolayer of highly polar lipids which forms 
naturally, since it is a physical property of the lipids which comprise 
it to form monolayers in water (Luzzati and Husson, '62). Weibel's 
electron microscopic description agreed well with what was postulated 
as the physical composition of the surfactant layer by earlier authors 
(Pattle and Thomas, '61; Klaus et al., '61; Clements, '67) based on 
biochemical data. 
The hypophase of the surfactant layer appears, for the most part, 
homogenous due to protein and mucopolysaccharide components. However, 
there are also surfactant lipids present in the hypophase which appear 
I 
I 
as characteristic "myelin figures" or lattice-like tubular myelin, due 
I 
I 
to the same physical forces which cause them to form monolayers (Klaus 
et al., '62; Balis and Conen, '64). ·These lipids are 80% phospholipids 
(King, '74) of which the major proportion is phosphatidylcholine and 
phosphatidylglycerol, with some phophatidylethanolamine and sphingo-
myelin (King and Clements, '72; Hallman and Gluck, '75; Van Golde, 
'76). The molecular species of phosphatidylcholine are also quite 
distinct, being mostly disaturated molecules and, in fact, predominant-
ly dipalmitoylphosphatidylcholine (DPC) which comprises about 50% of 
the total surfactant lipids (Toshima and Akino, '72; Van Golde, '76). 
8 
DPC owes its great surface activity largely to its bipolar molecular 
configuration - a hydrophilic choline group and two hydrophobic satu-
rated fatty acid side chains. This bipolar configuration causes it to 
form packed layers, and the presence of saturated side chains, as op-
posed to unsaturated, allows the molecules to be very tightly packed 
(Read, '71; Balis and Shelley, '72). Radioisotope studies have indi-
cated that the major pathway for the de novo synthesis of surfactant 
phosphatidylcholine is the CDP-choline pathway (Van Golde, '76). 
Some of the confusion concerning the surfactant layer of the 
alveolus was due to a long standing controversy as to whether the 
alveolar epithelium was a continuous epithelium, covering the capillary 
endothelial cells, or discontinuous, leaving the capillary cells ex-
posed directly to the air in the alveolus. In the early 1950's Low 
and co-workers published electron microscopic studies of mammalian 
lungs, which convincingly demonstrated for the first time tha,t the epi-
1 
; 
thelium of the alveolus was indeed continuous (Lmv and Daniels, '52; 
I 
Low, '53, '54; Low and Sampaio, '57). This work was substantiated by 
the similar findings of Karrer ('56) and Kisch ('60). It is now uni-
versally accepted that the alveoli of the mammalian lung are lined by a 
continuous layer of endodermally derived cells. The epithelial cells 
cru1 be characterized as two distinct types with particular, specialized 
functions. The type I cells cover the great majority of the alveolar 
surface and are essential for gaseous exchange in the lung. They are 
characterized by a central nucleus and wide, attenuated cell extensions 
which form the epithelial constituent of the three layered blood-air 
9 
barrier, the other two portions being a fused basal lamina and the pul-
monary capillary endothelium. The attenuated cytoplasm is approxi-
mately 0.1 to 0.2 ]Jm thick and thus may only be visualized using elec-
tron microscopy. The nuclear region is approximately 0.7 ]Jill thick and 
here are found the majority of the cellular organelles whichinclude 
mitochondria, Golgi complex and rough endoplasmic reticulum. The at-
tenuated cytoplasm contains few organelles but numerous pinocytotic ves-
icles which play a role in transepithelial transport. Contacts between 
type I cells, or between type I and type II cells, are typical "tight" 
junctions with close apposition of cell membranes. Synonyms for the 
type I alveolar epithelial cell include type-B cell, small alveolar 
cell, surface epithelial cell and membranous pneumocyte (Kilburn, '74). 
Interspersed among the type I cells are type II alveolar epithe-
lial cells which have also been called type-A cells, corner cells, 
vacuolated and non-vacuolated alveolar cells, septal cells ~d granular 
! 
pneumocytes (Kilburn, '74). The morphometric relationships OF alveolar 
I 
epithelial cells have been documented by Weibel ('76). In the lung of 
the adult rat he found the type II cells to cover far less surface area 
along the alveolar lumen than type I cells (69 ].1m2/cells vs. 4003 ].1m2/ 
cells). He also observed that type II cells are smaller than type I 
cells (336 ].1m2/cell vs. 812 ].1m2 /cell) but more numerous (14.1% vs. 
8.3% of lung parenchymal cells). 
The type II cells were first noted by Reinhardt in 1847 and so 
were resolvable by light microscopy. In paraffin sections they are 
easily confused, however, with alveolar macrophages, but are readily 
10 
studied in 1 to 2 Jllll plastic sections. They may be "tucked" away in a 
niche in the alveolar wall, or bulging out into the lumen, being ex-
pose¢ to air on the lateral surfaces of the cell. They may occur alone 
or in groups of two or three and tend to occur more often at points 
where several adjacent alveoli meet. 
The ultrastructure of the type II alveolar epithelial cells has 
been described by many authors including Macklin ('54), Karrer ('56), 
Balis and Conen ('64), Sorokin ('67), Kikkawa ('70) and others. The 
cells rest on a continuous basal lamina, have a diameter of from 7 to 
14 jlm, a spherical vesicular nucleus, which is frequently eccentric, 
and a nucleolus which is usually visible. They are roughly cuboidal 
but do exhibit a great amount of pleomorphism. The cells also exhibit 
some degree of polarity in that the apical surface is covered with 
short stubby microvilli which have fine axial filaments similar to 
those found in microvilli on the cells of other organs (Kuhn,
1 
'68). 
! 
Mitochondria are fairly numerous within the cytoplasm and are: seen as 
! 
"plump" or sometimes "rod-like" struc;:tures with parallel cristae. 
These cristae often fail to reach the center of the mitochondrion and 
\ 
are less numerous than those in mitochondria of other cell types, such 
as striated muscle (Sorokin, '67). Peroxisomes have been identified 
in type II cells of some species ·and are seen as enlarged bodies with a 
single limiting membrane (Schneeberger, '72). Lysosomes have also been 
observed by most authors and contain acid phosphatase and other hydro-
lases. There are usually two centrioles located apically in the cell, 
although they are seldom both seen in 'the same ultrathin section. One 
of these may, during cytodifferentiation, send out a short cilium into 
11 
the alveolar space; however, this never persists into the mature 
stage of the cell. 
The secretory nature of the cell is suggested by an abundant 
rough endoplasmic reticulum which is found throughout the cytoplasm 
of the cell, taking up much space between other organelles. The 
cisternae are loosely packed, differing in this respect from those 
of other secretory cells, such as pancreatic acinar cells. Some 
authors have described a flocculent precipitate within the ci~ternae, 
particularly when they are dilated (Sorokin, '67). Ribosomes are 
abundant on the cisternae as well as free within the cytoplasm, 
forming arrays. The Golgi apparatus appears in section to consist 
of both vesicles and stacks of lamellae in paranuclear, often apical, 
locations. In some cases there appear to be multiple vesicles of 
Golgi apparatus scattered widely throughout the cytoplasm. Multi-
vesicular bodies, although known to exist in other cells, such as 
I 
the ovum (Sotello and Porter, '59), are particularly prominerit in 
I 
I 
type II pneumocytes. These membrane bound structures may contain a 
few, or many, smooth surfaced vesicles and have been observed to 
incorporate Golgi vesicles (Sorokin, '67). 
The most unique structure to be found within the type II cell 
is what are now termed lamellar inclusion bodies. These are, or have 
been, also known as cytosomes, multilamellar bodies or alveolar 
inclusion bodies. Macklin ('54), using light microscopy, observed 
osmiophilic granules in the cuboidal alveolar epithelial cells and 
thus originated the term granular pneumocyte in reference to these 
12 
cells. In paraffin embedded tissue sections processed routinely these 
granules appear as empty holes or vacuoles. When lung tissue is pro-
cess,ed with minimal use of organic solvents, however, their contents 
stain intensely with osmium, periodic acid-Schiff, sudan black and 
toluidine blue. They are completely extracted by chloroform~methanol 
treatment. These and other histochemical reactions lead to the 
conclusion that the inclusion bodies contain lipids. By electron 
microscopy, lamellar inclusion bodies appear as roughly spherical or 
elongate, membrane bound and varying greatly in size. They consist 
of intensely osmiophilic lamellae, or membranes, which may be con-
centrically arranged or present in parallel arrays. Some problems were 
encountered in the study of the ultrastructure of the lamellar inclusion 
bodies in past years due to the partial or total extraction of their 
lipid content by polar dehydrants. Because of this Scarpelli ('68) 
suggested the adjective "lamellar" be omitted from their descriptive 
I 
title since the morphology of these inclusion bodies was undetermined 
I 
and variable from one report to the next. Studies utilizing the 
freeze-fracture technique (Lauweryns,and Gombeer-Desmecht, '72; Smith 
et al., '72) established that the lamellar inclusion bodies were indeed 
packed with lipid membranes. The periodicity of the membranes, however, 
remains controversial. Some (Pattle et al., '72; Lauweryns and Gombeer-
Desmecht, '72) have reported a 40 nm periodicity, while others (Smith 
et al., '72) felt a periodicity of 80 nm to be more accurate. Recently, 
the use of special lipid retention procedures, such as tannic acid fixa-
tion, has added considerably to the knowledge of the ultrastructure of 
the lamellar inclusion bodies. Stratton ('76), using these techniques 
13 
and high voltage electron microscopy, found a periodicity of 66 nm to 
be the most probable in vivo. 
In interpreting ultrastructural observations of the lamellar 
inclusion bodies, the problem of interspecies variation must be 
considered. The studies which have dealt with the periodicity of the 
lamellar membranes have employed primarily rat lung, where the lamellae 
are highly regular and densely packed. Kikkawa and Spitzer ('69) demon-
strated that a great deal of variation exists in the morphology of 
lamellar inclusion bodies among mammals. For example, the inclusion 
bodies of adult rabbits are somewhat vacuolated with far fewer membranes 
than those of the rat, while guinea pig inclusion bodies are inter-
mediate in terms of lamellar appearance. 
Some investigators have claimed that the type II cell is merely 
a phagocytic cell (Niden, '67). Others (Shulz, '59; Klaus et al., '62) 
suggested that the lamellar inclusion bodies are transformed kito-
I 
chondria. However, it is now well established that the type II cells 
are the source of pulmonary surfactant and that the lamellar inclusion 
bodies are the intracellular storage form of surfactant. Usin~ a 
method developed in 1938 (Sjostrand and Sjostrand), Macklin ('54) was 
the first to suggest that the "mucoid" film of' the alveolar space was 
secreted by the granular pneumocytes. Ten years later Balis and Conen 
('64) and Bensch ('64) reported a secretory function for the type II 
cells, based on the electron microscopic observation of lamellar 
inclusion bodies being secreted into the alveolar space. Similar obser-
vations have since been made by many investigators in the field (O'Hare 
14 
and Sheridan, '70; Smith et al., '79). Some have also claimed that 
this appearance might just as easily represent phagocytosis of sur-
factant material by type II cells. Detailed ultrastructural studies 
of the type II cell surface, however, have yielded evidence that the 
lamellar bodies are indeed being secreted from, not ingested by, the 
type II cell (Askin and Kuhn, '71). Moreover, it is thought that 
normal type II cells possess no phagocytic properties (Karrer, '60). 
Buckingham and Avery ('62) correlated the appearance of lamellar 
bodies in the fetal mouse with the first appearance of normal surface 
tension properties. This temporal relationship between the appearance 
of surface activity, the alveolar lining layer and lamellar inclusion 
bodies adds support to the concept of the lamellar bodies as intra-
cellular surfactant and has since been described in the rat (Buckingham 
et al., '64), rabbit (Kikkawa et al., '68), lamb (Kikkawa et al., '65) 
and human (Campiche et al., '63). Histochemical studies at the ultra-
t 
I 
I 
structural level have also indicated that the lamellar inclusion bodies 
consist of phospholipids very similar in all respects to those found in 
the surfactant layer of the alveolus (Campiche, '60; Sorokin, '66; 
' 
Dermer, '70), thereby linking the two. 
More recently, strong ~vidence in support of the relationship 
between lamellar inclusion bodies and surfactant synthesis has come 
from studies employing radiolabelled surfactant precursors. Askin and 
Kuhn ('71) administered 3H-palmitate intravenously to rats and found 
that it was incorporated primarily into the surfactant lipid lecithin. 
At all time periods studied they found heavy labelling of type II 
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alveolar cells and specifically the lamellar inclusion bodies. 
Chevalier and Collet ('72) studied the incorporation of several pre-
curso~s into lung epithelial cells, using electron microscopic auto-
radiography. 3 They observed that H-choline, a specific precursor of 
surfactant phosphatidylcholine, selectively labelled type II pneumocytes. 
In addition, they provided evidence that the lamellar inclusion bodies 
are formed through a process similar to that found in other secretory 
cells. After initial incorporation in the rough endoplasmic reticulum, 
the labelling was found progressively over the Golgi apparatus, the 
lamellar bodies, and then finally in the alveolar space over the 
myelin figures, which are thought to represent secreted surfactant. 
These findings have been substantiated by Massaro and Massaro ('72) 
in an autoradiographic study of intracellular surfactant protein transfer 
in type II cells. Although autoradiographic evidence has appeared which 
favors the view of the Clara cell of the terminal bronchiole as the 
I 
source of surfactant (Niden, '67; Etherton et al., '73), other reports. 
I 
have convincingly demonstrated that the secretion of the Clar1a cells is, 
in major part, proteinaceous in natu~e (Roth and Meyer, '72; Ebert et al., 
'76). In addition, comparative autoradiographic studies have ?lso 
added support to the concept of the type II cell as the source of 
surfactant (Adamson and Bowden, '73; Frasca, '77). 
Since the lung consists of over 40 individual cell types (Sorokin, 
'70), detailed biochemical or functional studies of type II cells alone 
have been lacking. Recently, however, some investigators have been 
able to isolate relatively pure populations of viable type II cells. 
~ikkawa and Yoneda ('74) were the first to accomplish this in rat lung, 
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and with co-workers ('75) published a valuable study of the composi-
tion and synthetic activity of type II cells. Others (Fisher and 
Furip, '77; Mason et al., '77; Pfleger, '77) have since accomplished 
similar isolations and have contributed information concerning the 
role of the type II alveolar epithelial cell in surfactant synthesis, 
storage and release. 
Through the various lines of evidence discussed above, and 
innumerable studies, the following scheme of lamellar body synthesis 
and surfactant secretion has been well established. The lipids and 
proteins are synthesized in the rough endoplasmic reticulum and passed 
on to the Golgi apparatus, where vesicles are "pinched" off and 
packaged as multivesicular bodies. These then undergo a lamellar 
transformation to mature inclusion bodies while approaching the apex 
of the cell. Upon reaching the apex the limiting membrane of the 
lamellar body fuses with the cell membrane, and the membranous contents 
I 
of the inclusion body are discharged into the hypophase of th~ existing 
I 
alveolar lining layer. In the alveolar space the molecules of sur-
factant may take part in forming the 4 nm thick surface active film, 
or remain in reserve in the hypophase, forming myelin figures or 
tubular myelin arrays. The process of the lamellar body membranes 
unfolding and rearranging to form tubular myelin arrays in the hypo-
phase has recently been convincingly demonstrated by the use of high 
voltage electron microscopy (Williams, '77; Sanderson and Vatter, '77). 
To complete the story, "used" surfactant is thought to leave the 
alveolar space in several ways. It may flow up the respiratory tree, 
be phagocytized by the alveolar macrophages present in the hypophase, 
be absorbed through the alveolar epithelium or enzymatically de-
graded in situ (Goerke, '74). 
Fetal Lung Development 
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The lungs of all mammals, including man, which have been studied 
during the course of their development have been found to share a com-
mon pattern of origin, development and maturation. The epithelium of 
the respiratory tract originates as a diverticulum from the endoderm 
of the caudal pharynx (Moore, '73; YokohJ '77). This diverticulum 
elongates as the laryngotracheal tube, developing lung buds which 
grow and divide by dichotomous branching to form primitive respira-
tory passages. The mesenchyme surrounding the endodermal outgrowth 
is destined to become the smooth muscle, cartilage and blood vessels 
of the lung. It has been shown that specific interaction between the 
endoderm and mesoderm is essential for normal lung growth and cellular 
differentiation (Taderara, '67; Masters, '76). 
Further development of the lung may be divided into three major 
periods. The glandular (pseudogland~lar) period is the earliest and 
is so called because the microscopic appearance of the lung at this 
stage resembles glandular tissue. The air conducting system develops 
during this period and the potential airways are lined by a low 
columnar to high cuboidal epithelium. Also during this period, the 
mesenchymal mass around the airways is condensing. The canalicular 
period is characterized by enlarging respiratory passages which are 
lined by cuboidal epithelium, by a vascularization of the surrounding 
mesenchyme and by the appearance of primitive respiratory bronchioles 
and what may be termed alveolar septa (Conen and Balis, '69). The 
/ 
alveolar period is the final stage of development and is character-
ized.by the massive proliferation of alveoli and the thinning of the 
the alveolar septa. Concurrent with this is the development of the 
great majority of the blood-air barriers which will be requi'red for 
gaseous exchange. Since only 1/8 to 1/6 of the adult number of 
alveoli are present in the lungs at birth, in the human this stage is 
said to continue up till the age of ten years (Moore, '73). 
Although it was generally accepted that the epithelium of the 
air conducting system was an endodermal derivative, the germ layer 
origin of the alveolar epithelium was, for a time, in question. 
Policard et al. ('57) felt that both the type I and type II alveolar 
epithelial cells were of mesodermal origin. Many investigators, 
influenced by its reported phagocytic characteristics, believed that 
the type II cell was of mesodermal origin, as is the alveola~ macro-
t 
phage (Divertie and Brown, '64; Bertalanffy, '64). Others (Lpw and 
I 
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Sampaio, '57; Campiche et al., '63; Suzuki, '66) thought that a common 
endodermal origin was more likely, judging by the junctional complexes 
' between type I and type II cells and the presence of a common basal 
lamina. Morphologic (Kikkawa et al., '68; O'Hare and Sheridan, '70) 
and autoradiographic (Hitchcock, ·'68) studies have established the 
concept of a common endodermal derivation for all the respiratory 
passages, including both types of alveolar epithelial cells. 
The mature type I and type II epithelial cells which are found 
in the alveolus of the term fetus both stem from a common immature 
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cuboidal cell which is already present at the canalicular phase of 
development. The internal organization of this undifferentiated cell 
is relatively simple, in that a great deal of the cytoplasm is filled 
with fairly densely packed glycogen and varying, usually small, amounts 
of rough endoplasmic reticulum. A few mitochondria are also present, 
but inconspicuous, and the Golgi is normally lacking. Lamellar inclu-
sian bodies or multivesicular bodies are not present. If a given 
immature cuboidal cell is destined to become a type I cell, extensions 
begin to grow out from its lateral borders while a gradual thinning 
of the entire cell takes place (Balis et al., '66; Adamson and Bowden, 
'75). The internal organization of the cell remains at about the 
same simple level of the undifferentiated cell, although occasionally 
a poorly formed lamellar inclusion may be observed (Mercurio and 
Rhodin, '76). This, however, is occasionally true of type I cells in 
the adult lung as well (Kikkawa and Kaibara, '72). The major intra-
cytoplasmic change which occurs during the differentiation o~ type I 
! 
cells is the loss of glycogen as the extensions thin to form blood-air 
barriers. As these blood-air barrie~s mature, they become thinner 
by the attenuation of the type I epithelium and, often, by the,reposi-
tioning of the capillary cell nucleus. At earlier stages these nuclei 
lie directly under the epithelial component of the blood-air barrier 
but, as maturation proceeds, they come to lie at the opposite pole of 
the capillary, toward the alveolar septa. 
The same immature cuboidal cells may also undergo major changes 
during the differentiation to mature type II cells. These changes all 
correspond with the cell developing the cytoplasmic specializations 
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required for the manufacture and secretion of pulmonary surfactant. 
A cuboidal cell which lines the fetal alveolus may be termed a type II 
cell~ as such, at the first appearance of lamellar inclusion bodies. 
This occurs rather late in gestation and, as mentioned, is one 
criterion which helped link the lamellar inclusion bodies to the 
synthesis of surfactant. Of course the secretory apparatus which 
manufactures the surfactant is also becoming highly developed during 
this same time. 
One of the hallmarks of the differentiation of type II cells 
from their immature cuboidal precursors is the loss of the glycogen 
content which had been built up by the immature form (Brandstrup and 
Kretchmer, '65; Kikkawa, '68). It is thought that this decrease in 
glycogen content occurs because of the increase in surfactant synthe-
sis. Glucose has been shown to be an important precursor for phos-
phatidylcholine synthesis in the adult rabbit lung (Felts, '~4), and 
there is indirect evidence that glycogen is a precursor for, :or is 
! 
somehow necessary for, phosphatidylcholine synthesis in fetal rabbit 
lung (Gilden et al., '77). Finally, as the cell matures there occurs 
I 
an increase in the number of lamellar inclusion bodies and their 
precursor forms, multivesicular bodies. 
This basic scheme of differentiation and maturation in the 
alveolar epithelium has been studied in many mammals including the 
human (Balis and Conen, '64; Campiche, '63; McDougall and Smith, '75), 
lamb (Kikkawa et al., '65), rat (O'Hare and Sheridan, '70; Hilliams, 
'77), mouse (Woodside and Dalton, '58), pig (Baskerville, '76) and 
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hamster (Banks and Epling, '71). Kikkawa and co-workers ('68, '71) 
and Motoyama et al. ('71), working with Kikkawa, have contributed 
greatly to the understanding of the morphologic development of the 
alveolar epithelium in the rabbit. Their findings may be summarized 
as follows: On the 21st gestational day a columnar epithelium contain-
ing a moderate amount of glycogen lined the respiratory passages. 
These cells also contained quite a few profiles of rough endoplasmic 
reticulum which, in some cases, were distended. The Golgi apparatus 
was often present, but inconspicuous. The alveolar epithelium of the 
24th gestational day was characterized by the presence of large amounts 
of glycogen packed densely into the cells. The cells also contained 
a few mitochondria and rough endoplasmic reticulum similar to that 
observed at the 21st gestational day. Various oval shaped, electron 
dense bodies were found in the vicinity of a well defined Golgi. In 
26 day fetal rabbit lungs they observed some differentiation lof the 
alveolar epithelium into type I and type II cells. The type :I cells 
I 
at this point contained no glycogen ?nd were already fairly well 
attenuated. The type II cells contained large amounts of glycogen, 
some lamellar inclusion bodies and an occasional multivesicular body. 
Fetal lung examined at 27 days showed type I and type II cells which 
were fairly well differentiated, ·and a further decrease in the glyco-
gen content of the type II cells. At 28 days of gestation Kikkawa 
concluded that the fetal rabbit lung, including the type II epithelial 
cells, was completely mature. He based this primarily on the lack 
of glycogen, the presence of blood-air barriers and the observation 
of relatively numerous lamellar inclusion bodies. 
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Kikkawa has also described a maturation process for the lamellar 
inclusion bodies within the fetal rabbit type II cells ('69). The most 
imm~ture of the inclusion bodies are uniformly electron dense with 
perhaps one or two lamellae within them and were termed "dense bodies" 
by Kikkawa. "Transitional forms" were the next stage of the matura-
tion process and were characterized as possessing a number of well 
formed lamellae with varying amounts of amorphous, electron dense 
material in the center. Finally, "fetal inclusions" were the most 
mature forms described by Kikkawa and consisted of many well formed 
lamellae. The mature lamellar inclusion body of the fetal rabbit lung 
possesses many more lamellae than that of an adult rabbit, although 
the reason for this difference has not become clear. Recently, this 
high degree of lamellar development in fetal rabbit inclusion bodies 
has been confirmed by the application of freeze-fracture techniques 
(Kikkawa and Manabe, '78). 
I 
I 
Any study dealing with the maturation of the fetal lung: has had 
I 
I 
to take into account the fact that different portions of the lung 
mature at different rates. Howatt et al. ('65) observed that the 
\ 
upper lobes of premature newborn lambs were more compliant and that 
surfactant appeared earlier here than in the lower lobes. Kikkawa 
et al. ('71), using morphologic c!riteria, reported that the apex of 
the right upper lobe of the fetal rabbit lung was advanced 1.5 gesta-
tiona! days beyond the maturational stage of the base of either lower 
lobe. 
Cellular proliferation in the fetal lung is .also of interest in 
describing maturational changes occuring prenatally. Sorokin ('61) 
demonstrated that the mitotic index of lung parenchymal cells de-
creased with advancing gestational age. In an extensive autoradio-
graphic study of cell proliferation in fetal rat lung, O'Hare and 
Townes ('70) reported that the labelled cell indices of alveolar 
epithelial cells and lung interstitial cells was constant in the mid-
portion of gestation, but abruptly decreased in late gestation. They 
administered tritiated thymidine to pregnant rats and, in others, in-
jected colchicine in order to study mitotic indices. The results of 
the two studies showed comparable trends and thus provide evidence 
that the 3H-thymidine indices are accurate reflections of mitotic 
activity in fetal lung cells. They also concluded that the decreas-
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ing mitotic and labelling indices paralleled the reduction of glycogen 
levels in pulmonary epithelial cells. Essentially the same results 
were reported by Kauffman ('75) in a similar autoradiographic study 
I 
of cell proliferation in fetal mouse lung. She concluded th~t the 
' decrease in cell proliferation in late gestation was due to the fact 
that the cells undergoing differentiation were removed from the pro-
liferative "pool" of earlier gestational ages due to a significant 
increase in cell cycle time. 
Scintillation Autoradiography 
Although the foregoing studies utilized autoradiography, they 
illustrate a drawback which is common to all autoradiographic studies, 
the length of time necessary to obtain adequate exposure of the emu!-
sion. The technique of scintillation autoradiography was pioneered by 
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Panayi and Neill ('72) based on a somewhat similar technique which had 
been previously described for use in paper chromatography (Wilson, 
('58) and thin layer chromatography (Luthi and Waser, '65). By dip-
ping emulsion coated slides in a scintillation mixture, Panayi and 
Neill were able to reduce the exposure time to one day in a'study of 
cell division in lymphocyte cultures. Durie and Salmon ('75) also 
studied blood cell division using this technique and were able to 
shorten the exposure time to six hours by the use of tritium with a 
high specific activity. Platkowska ('76) employed stripping film 
autoradiography and a scintillation mixture in a study which employed 
6 ~m paraffin tissue sections as well as lymphocyte smears. This 
technique has also been applied to the study of chromosomal DNA syn-
thesis in the lily plant (Sen et al., '77) and drosophila (Mukherjee 
and Chatterjee, '77). In the only study to date using plastic embed-
ding, Fischer et al. ('71) used a related technique of mixing scin-
tillator with Epon resin and obtained electron microscopic aJtoradio-
graphic results after 14 days of exposure. 
Respiratory Distress Syndrome of the Newborn 
Interest in the type II epithelium, its maturation and the 
secretion of surfactant in the fetus was stimulated by the observa-
tion of Avery and Mead ('59) that the lungs of infants who had died of 
respiratory distress syndrome of the newborn (RDS) lacked sufficient 
amounts of pulmonary surfactant. RDS afflicts approximately 1,000 
premature infants per week in the United States alone (Gluck, '73) 
and although therapeutic measures designed to .date have increased the 
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likelihood of survival, it remains a major disease with a high mor-
tality rate. Those infants who do survive often develop neurologic 
and;intellectual deficits due to the significant post-natal anoxia 
associated with RDS. 
The clinical disease entity as such has been the subject of ex-
cellent reviews (Villee et al., '73; Farrell and Avery, '75) and 
therefore only morphologic features relevant to this project will be 
discussed briefly. It has been clearly demonstrated that the lungs of 
most infants who develop RDS are at an immature stage of maturation at 
birth, in that the alveoli are predominantly lined by characteristi-
cally immature type II epithelial cells and possess relatively few 
blood-air barriers (Balis et al.,'66). This anatomic immaturity of 
the lung may lead to a deficiency of surfactant secretion, difficulty 
i.n inflating the lung at birth and consequent expiratory atelectasis. 
Anoxia and other factors lead to necrosis of type I epitheliqm and 
i 
i 
increased transudation of plasma proteins. This results in fprmation 
I 
of the characteristic hyaline membranes found at autopsy in the lungs 
of infants who succumb to RDS. Lungs of infants who survive follow-
ing therapeutic management show a regenerated alveolar epithelium, com-
posed of immature type II cells, which progressively matures. It 
should be emphasized that the pr~cise structural, functional and bio-
chemical characteristics of the infant lung at birth, with or without 
RDS, have not been well documented and many in utero factors may 
influence these characteristics. 
The normal infant, possessing a mature lung whose alveoli 
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contain sufficient surfactant at birth, retains 50% of the air which 
it inhales with its first breath (Karlberg et al., '62). This func-
tional residual volume is the hallmark of pulmonary maturity and what 
is decidedly lacking in the premature infant with insufficient surfac-
tant at birth. 
Drug Induced Alterations of Fetal Lung Maturation 
The findings of Avery and Mead ('59) have been substantiated by 
many investigators. This established relationship between RDS, lung 
surfactant and the maturity of the type II alveolar epithelium led to 
investigations concerned with factors which could possibly influence 
the maturation of the type II epithelial cells and the production of 
surfactant in the fetus. Buckingham et al. ('68) were the first to 
propose that glucocorticoids might accelerate lung cell differentia-
tion. They theorized that 
stimulatory effect on cell 
developing digestive tract 
since glucocorticoi~s were known ~o have a 
differentiation in the epithelium pf the 
I 
(Moog and Richardson, '55) they might also 
have this effect on the epithelium of the fetal alveolus since it too 
is an endodermal derivative. 
Liggins ('69) administered glucocorticoids to pregnant sheep 
and found that when he delivered the lambs prematurely, they survived 
significantly more often than control lambs delivered at the same 
gestational age. Direct injection of cortisol into rabbit fetuses 
in utero has been morphologically demonstrated to accelerate the matu-
ration of type II alveolar epithelial cells (Kikkawa et al., '71; 
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Motoyama et al., '71). This conclusion was based on an earlier 
decrease in glycogen content associated with an increase in the number 
of lamellar inclusion bodies present within the type II pneumocytes. 
In addition, type I cells began the attenuation process sooner, re-
sulting in the appearance of blood-air barriers at an earlier stage 
of gestation than in controls. Related findings indicating increased 
maturation in the lungs of glucocorticoid-treated rabbit fetuses have 
also been reported by Wang et al. ('71) and Kotas and Avery ('72). 
In order to rule out the interference of other hormones which may have 
been stimulated through pituitary feed-back loops, Blackburn et al. 
('72) using rats and Chisweck et al. ('73) using rabbits, decapitated 
fetuses in utero and studied type II cell maturation. The results of 
both studies indicated a retardation of type II cell differentiation 
with decreased numbers of lamellar inclusion bodies present within the 
cells. However, in the study of Chisweck, when a synthetic analog of 
I ACTH was administered to the fetal rabbits, these changes wer.e 
I 
I 
abolished, indicating a possible hypophyseal controlling mechkmism 
for lung maturation in vivo. 
' Since the first experiments of Liggins, there has appeared a 
wealth of literature documenting the acceleration of maturation of the 
fetal lung following glucocorticoid treatments (for review see Farrell 
and Avery, '75). In addition, controlled clinical trials have been 
implemented which have suggested that the administration of steroids 
to pregnant mothers 1-2 days prior to delivery may decrease the inci-
deuce of RDS in high risk pregnancies, but is only effective if deliv-
ery occurs before the thirty-second week of gestation (Liggins and 
Howie, '72) • 
As promising as the foregoing studies appear to be, however, 
glucocorticoid administration has not gained universal acceptance as 
the clinical answer to RDS. Although there have been reports of de-
( 
creased cortisol levels in infants afflicted with RDS (Murphy, '74), 
others have indicated no such decrease and, indeed, found elevated 
cortisol levels in infants similarly afflicted (Reynolds, '73). In 
addition to the problem of tl\ese conflicting clinical reports, some 
studies have revealed possible deleterious effects of steroid treat-
ment of the fetus and/or newborn. Kotas et al. ('74) and Carson 
et al. ('73) have documented an inhibition of total lung cell number 
after hydrocortisone therapy in fetal rabbits. Picken et al. ('74) 
found that the administration of corticosteroids, on a longer term 
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basis, resulted in a significant increase in the elastic recoil of the 
lungs in treated animals and the appearance of "giant" lamellar bodies 
I 
within the type II cells. They concluded that the long-term ladmin-
\ 
istration of glucocorticoids resulted in a decided impairment of 
surfactant secretion. In addition to these possible deleterious 
effects in the lung, other, far reaching, problems have been reported 
following corticosteroid administration. Impaired cellular develop-
ment of the cerebrum and cerebellum was observed in rats treated post-
natally with steroids (Cotterrell et al., '72) and neurologic deficits 
including impaired motor co-ordination and balance were reported in 
mice following similar treatment (Howard and Granoff, '68). Older 
reports of side effects in the glucocorticoid therapy of human infants 
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also hold significance. Treating premature infants with ACTH for 
retrolental fibroplasia, Silverman et al. ('51) observed a retardation 
of growth which was reversible following the cessation of treatment. 
In addition, neurologic deficits were described by deLemos and 
Haggerty ('69) following prednisolone therapy of infants suffering 
from bacterial meningitis. More recently, several reports have ap-
peared dealing with previously unknown side effects of the clinical 
trials of steroid therapy for RDS which were attempted. Taeusch et 
al. ('73) as well as Ewerbeck and Helwig ('72) have reported extensive 
intraventricular hemorrhages following steroid treatment. In addition, 
various neurologic abnormalities have also been reported as long-term 
sequelae of such clinical steroid intervention for RDS (Fitzhardinge 
naL, '74). 
Because of the conflicting reports of the usefulness and possi-
ble deleterious side effects of corticosteroid treatment for !the pre-
vention and/or treatment of RDS, investigations have begun in:to the 
I 
I 
possibility of influencing fetal lung maturation through other means. 
Other agents which are thought to be capable of affecting the matura-
tion of the fetal lung are discussed in reviews by Cowan ('74)\and 
Avery ('75). The list of such agents now includes ~hyroxine (Wu et 
al., '73), aminophyllin (Karotkin et al., '76), prolactin (Hamosh and 
Hamosh, '77), plasminogen (Ambrus et al., '77) and heroin (Taeusch et 
al., '73). In addition, there has been an increase in studies design-
ed to ascertain the mechanisms at work in vivo which control the 
maturation of the lung and the initiation of surfactant synthesis and 
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secretion in the fetus. 
Autonomic Manipulation of the Surfactant System 
The first indication that the parasympathetic nervous system 
could be involved in the maintenance of the type II alveolar'epithe-
lium and the secretion of surfactant came from studies of vagotomized 
animals. Early investigators in the surfactant field had noted ab-
normal alveolar surface tension (Klaus et al., '62) as well as mor-
phologic changes in type II alveolar cells (Eolande and Klaus, '64) 
in the lungs of vagotomized animals. In addition, Miller et al. ('51) 
--
observed hyaline membranes similar to those found in the lungs of 
infants who had succumbed to RDS. Goldenberg et al. ('67) performed an 
in depth study of the ultrastructural changes in alveolar type II 
cells of rats following bi-lateral cervical vagotomy. They described 
a severe loss of osmiophilia and membrane structure within the lamel-
1 
lar inclusion bodies as quickly as one hour post-vagotomy. They also 
! 
I 
I 
observed a loss of multivesicular bodies and changes in the secretory 
apparatus of the type II cells. They concluded that intact vagal 
connections were a necessity for normal surfactant production ~nd 
secretion. Based on these findings, they reasoned that a parasympa-
thomimetic should have a stimulatory effect on surfactant secretion. 
They chose to try pilocarpine (Goldenberg et al., '69) a cholinomime-
tic (parasympathomimetic) alkaloid which is used by ophthalmologists to 
increase the secretion of the aqueous humor in the treatment of glauc-
oma. The principle action of pilocarpine is the stimulation of the 
same autonomic effector cells which are acted upon by cholinergic 
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post-ganglionic nerve impulses. The compound is obtained from the 
leaflets of two South American shrubs (Pilocarpus jaborandi and 
Pilocarpus microphyllus) and is commercially available as pilocarpine 
nitrate or, as used by Goldenberg and associates, pilocarpine hydro-
chloride. 
The pharmacologic properties of pilocarpine mimic, for the most 
part, a massive parasympathetic stimulation. Administration of 10-15 
mg in man causes marked diaphoresis, salivation, lacrimation and in-
creased secretion of the pancreas and gastrointestinal glands. Pilo-
carpine also causes a generalized increase in smooth muscle tone in 
most organs, including the gastrointestinal tract, respiratory tract, 
biliary system and urinary system. The only exception to its general 
parasympathetic-like effects are an increase in heart rate and hyper-
tension. It is thought that this is due to a limited stimulation of 
sympathetic ganglia (Koelle, '75). 
I 
Goldenberg and associates ('69) injected adult fasted rats with 
a single subcutaneous dose (150 mg/kg) of pilocarpine and sacrificed 
them at .5, 1, 2, 4, 7, 10, 14, 18, 21 and 24 hours after injeption. 
By light microscopy they observed a dilatation of the alveoli and the 
presence of apparently proteinaceous material within the bronchiolar 
and alveolar lumina soon after injection. By 24 hours post-injection 
the alveoli were either collapsed or dilated. Electron microscopy of 
the type II alveolar cells at .5 hours post-injection revealed a mas-
sively dilated rough endoplasmic reticulum which contained abundant 
granular material. At one hour they noted a significant increase in 
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the numbers of multivesicular bodies present within the type II cells. 
Examination at two hours following pilocarpine administration revealed 
larg~, highly osmiophilic lamellar inclusion bodies within the type 
II cells and an increase in the amount of intra-alveolar membranous 
material. Four hours post-injection the type II cells contained 
groups of large, mature inclusion bodies which were gathered at the 
apex of the cell. These were frequently observed to be discharging 
their contents into the alveolar space. The type II cells at seven 
hours contained relatively few inclusion bodies and thereafter return-
ed to the appearance of controls. Based on these observations, 
Goldenberg and co-workers concluded that pilocarpine had a frank 
stimulatory effect on the exocrine secretory mechanism of the alveolar 
type II cells which was maximal at 2-4 hours after injection. 
This stimulatory effect of pilocarpine was substantiated by 
Petrik's report ('69) of "grill structures" in the bronchiolels of mice 
I 
which had received the same dosage of pilocarpine used in Golpenberg's 
study. These structures were what are now termed tubular myelin 
arrays and represent surfactant. Kirkland ('70) reported a reduction 
in the surface tension of lung extracts in rats treated with pilocar-
pine, and concluded that this was due to an increase in the amount of 
pulmonary surfactant which had been released into the alveolar space 
in treated animals. At about the same time Ivemark and Robertson 
('70), in a short report of a study dealing primarily with the effects 
of high vitamin A, mentioned an increased phospholipid content and 
lower minimal surface tension of lung extracts in rats treated with 
pilocarpine. Morgan and Morgan ('73) administered 1.5 mg/kg pilo-
carpine intra-peritoneally to rats while simultaneously injecting 
14
c-palmitate into the left atrium via an in-dwelling catheter. The 
phospholipids from lung washes and homogenates of these rats were 
separated by thin layer chromatography and analyzed for lipid phos-
phorus and radioactivity. They found that pilocarpine significantly 
increased lecithin tum-over rates due to an increased secretory 
activity in type II cells. Massaro ('75), in order to study the 
secretion of the protein portion of pulmonary surfactant, injected 
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radiolabelled leucine as well as 3 mg/kg pilocarpine to adult rabbits. 
By isolating the surface active fraction from lung lavages and assay-
ing for protein, he found that pilocarpine caused a 2.5 fold increase 
in the percentage of radiolabelled surfactant protein. 
The anatomical connection between the autonomic nervous system 
and the alveoli of the lung was first suggested by Meyrick aid 
(' 71) who reported electron microscopic observations of nerve'~ 
I 
Reid 
in the 
alveolar walls of rats. These were thought to correspond to those 
previously demonstrated by light microscopy (Hirsch et al., 68). Hung 
' 
et al. ('72), using electron microscopy, demonstrated an abundance 
of nerves in the walls of alveolar ducts and alveoli of mice. They 
reported finding such nerves in every section of every block they ex-
amined from 18 different mouse lungs and, furthermore, reported find-
ing two distinct types of nerve endings. The first type had an en-
larged terminal containing many small mitochondria and was found in 
the pulmonary interstitium, either alone or related to type I pneuma-
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cytes. The second type of nerve ending was described as being packed 
with large dense-core vesicles and forming an enlargement adjacent to 
typ~ II pneumocytes. 
The first type of nerve ending described by Hung and co-workers 
resembled typical sensory endings and were theorized as being such. 
The second type, although fewer in number than the first, are far more 
unique, since they provide the morphologic connection between the auto-
nomic nervous system and surfactant secretion. This type of nerve 
ending in the lung most closely resembled a type of axon found in the 
pars tuberalis of the pituitary, as reported by Unsicker ('71). Hung 
and colleages theorized that the substance in the dense-core vesicles 
of the terminal, upon vagal stimulation, would diffuse out of the axon 
and effect not only the type II pneumocyte adjacent to it, but also 
others at some distance away. The first type of ending, the sensory 
portion, was also thought to be of vagal origin, making both !afferent 
I 
and efferent pathways vagal. Stimulation of the left vagus i~ rabbits 
by Oyarzun and Clements ('77) resulted in a bi-lateral increase in 
alveolar phospholipids, apparently due to crossing over of fibers in the 
I 
rabbit vagi. Oyarzun and Clements also reported a similar effect in 
rabbits subjected to substantial increases in ventilation. This effect 
could, however, be completely bldcked by atropine which led them to 
conclude that, although the exact neural or humoral pathway for this 
reflex increase in surfactant following increased ventilation was 
unknown, it was reasonable to expect that the effect was mediated 
through cholinergic mechanisms. 
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In addition to pilocarpine, another parasympathomimetic, 
oxotremorine, has been implicated as having a stimulatory effect on 
surfactant secretion. Abdeblatif and Hollingsworth ( '77) reported that 
an intra-peritoneal injection of oxotremorine to neonatal rabbits 
resulted in a significant increase in the phosphatidylcholine (PC) 
content of alveolar washes. Because they found no increase in the PC 
content of the residual lung, however, they concluded that the drug 
did not affect production. This conclusion, however, may not be valid 
since they sacrificed the animals thirty minutes after injection and 
an effect on production of surfactant would not be expected until 
perhaps two hours. 
In 1976 Corbet et al. published the results of the first study 
dealing with the effects of pilocarpine on the surfactant system in 
the fetus. They injected 150 mg/kg pilocarpine in 0.1 ml of saline, 
or saline alone, intra-peritoneally to fetal rabbits of gestational ages 
i 
i 
25.5, 26.5, 27.5, 28.5 and 29.5 days. This was accomplished by anes-
1 
thetizing the pregnant does with methoxy-flurane, performing a lapar-
otomy and injecting the fetus through the intact uterine wall. The 
abdomen of the does was then closed, to be re-opened 2.5 hours after 
injection. Fetal lung was then obtained and pressure-volume studies 
performed on intact lungs. Corbet and associates found that, in fetal 
lungs from rabbits of 25.5, 26.5 and 27.5 gestational days, this pilo-
carpine treatment resulted in substantial improvement of retention of 
air on deflation to low pressures. This would indicate an increase 
of surface activity '"ithin the alveoli, and thus an increased secretion 
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of surfactant. They found, however, no significant differences from 
controls in fetuses of 28.5 or 29.5 gestational days and interpreted 
this; as indicating that the lungs were already functioning at minimal 
surface tension without the pilocarpine stimulus. 
In a related study Pysher et al. ('77) using explants of fetal 
lung in culture observed that, at a concentration of 10-6 M, pilocar-
pine significantly increased the release of radiolabelled lecithin 
after three hours of incubation. 
In order to clarify the mechanism of action of pilocarpine in 
the fetal lung Corbet et al. ('77) performed another study, this time 
using various autonomic agents and their antagonists. Employing the 
same operative procedure used in their earlier study, they adminis-
tered saline, pilocarpine, muscarine (a parasympathomimetic similar in 
action to pilocarpine), atropine (a cholinergic antagonist), isox-
suprine (as-adrenergic agonist), propranolol (a s-adrenergi~ antago-
I 
nist), phenylephrine (an a-adrenergic agonist) and phenoxyben~amine 
(an a-adrenergic antagonist) alone or in appropriate combinations. 
They found the stimulatory effect of pilocarpine on the secret~on of 
su~factant in the fetus to be blocked by either atropine or propran-
olol. The stimulatory effect was mimicked by isoxsuprine, which could 
not be blocked by atropine but could be by propranolol. Muscarine had 
no stimulatory effect, nor did phenylephrine. These and the results 
of other combinations, led Corbet and co-workers to conclude that the 
action of pilocarpine is due to a stimulation of S-adrenergic receptors, 
possibly on the surface of type II alveolar epithelial cells. The 
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nerve endings which were reported by Hung et al. ('72) would, in 
Corbet's view, then be sympathetic, S-adrenergic in nature. 
This theory gains some measure of support from other reports of 
the action of isoxsuprine (the s-adrenergic agonist) in the fetal lung. 
( 
Enhorning et al. ('77) injected isoxsuprine intra-muscularly to rabbit 
fetuses at the 28th gestational day and reported an increase in sur-
face activity of the lung wash. Hayden et al. ('77) treated rabbit 
fetuses at 26.5 gestational days with three doses of isoxsuprine, eight 
hours apart, sacrificed the animals 26-30 hours after the last injec-
tion and observed an increase in lung lecithin over control values. 
In a clinical sur~ey of newborn premature infants whose mothers had 
been treated with ritodine (another s-adrenergic drug) prior to deliv-
ery, Boog et al. ('75) reported a decreased incidence of RDS when 
compared to fetuses of similar birth weight born to mothers receiving 
no such treatment. In another clinical case review Hastwell ,('77) 
i 
' reported a possible therapeutic benefit o~ salbutomol (anothe\ S-adre-
' 
nergic agent) in preventing RDS in infants born prematurely. 
Although the preceding studies seem to indicate that sympathetic 
activation would stimulate the secretion of surfactant, there exists 
some dispute in the literature. Bergren and Beckman ('76) reported 
decreased lung compliance, indicating decreased surfactant, in animals 
following sympathetic stimulation. Beckman et al. (' 71) had previously 
found similar results in monkeys following head injury and reported 
that this effect was due to sympathetic activation, since it could 
be blocked hy sympatholytic agents. 
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None of the studies to date dealing with the autonomic manipula-
tion of the fetal lung surfactant system has described morphologic 
changes following administration of autonomic drugs. Furthermore, 
all of the previous studies have involved the direct injection of the 
autonomic agents to fetuses while in utero. This procedurer'involves 
surgical trauma to both the mother and fetus prior to the administra-
tion of the drug, in addition to possible effects of the anesthetic 
used. That this is not the ideal situation is pointed out by the 
findings of Robert et al. ('75) which indicated that the lungs of 
fetuses injected with saline in this manner showed evidence of a marked 
acceleration of maturation, when compared to similar fetuses of non-
operated mothers. 
MATERIALS AND METHODS 
Animal Care and Mating 
Large white New Zealand rabbits (average approximately 3.2 kg) 
I 
were procured from Langshaw Farms (Augusta, Michigan) and used for 
all experiments. All animals were housed in the same room under 
identical conditions. They were fed a standard diet of approximately 
90 g of lab chow (Wayne rabbit ration) per day and were allowed water 
ad libitum. In some cases the amount of water intake by a given 
rabbit was recorded daily. The external genitalia of the females 
were examined periodically in order to determine which animals would 
be receptive to the males. Females judged to be receptive were placed 
in the cage of a male and held in place while mating was accomplished. 
This procedure was then repeated with a second male. Mating was always 
completed within a fifteen minute period between the hours o~ 2 and 
4 PM. The time of mating was recorded and considered to be t~me zero 
of gestation. 
Experimental Protocols 
Table I lists the types of experiments performed in this study 
along with the numbers of litters employed in each type. 
Multiple Injections (Standard Regimen) --28 days 
A solution containing 20 mg pilocarpine hydrochloride (Sigma 
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TABLE I 
EXPERIMENTAL PROTOCOLS 
Gestational Number of Pilocarpine Time After First 
Age Litters Dosage Injection 
at Sacrifice Animal Killed 
Standard Regimen 
Control 28 18 
31 2 
Pilocarpine 28 15 5 mg/kg-4 days 4 days 
31 2 II 7 days-
Time-Course 
Control 25 2 
26 2 
27 2 
29 2 
30 2 '-
Pilocarpine 25 2 5 mg/kg-1 day 1 day 
26 2 5 mg/kg-2 days 2 days 
27 2 5 mg/kg-3 days 3 days 
Single Injection 
Control 27 3 
28 4 
29 11 
30 2 
Pilocarpine 27 2 20 mg/kg 6,24 hours 
28 3 20-40 mg/kg 3,24 hours 
29 17 10-80 mg/kg 2,3,6,12,24 hours 
30 2 10,15 mg/kg 24 hours 
31 2 10 mg/kg 24 hours 
Injection of 
Fetuses in utero 
Control 27 1 24 hours 
and 
Pilocarpine 28 1 10 mg/fetus 24 hours 
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Pharmaceutical) per ml of 0.9% saline was prepared fresh for each set 
of experiments. On the 24th gestational day pregnant female rabbits 
were;weighed and a dose of 5 mg pilocarpine per kg of body weight was 
prepared by diluting the appropriate amount of the previously prepared 
stock solution of pilocarpine to 1 ml with 0.9% saline. This was then 
placed in a 1 ml tuberculin syringe and injected subcutaneously in the 
region of the upper back of the pregnant female rabbit. Controls were 
injected with 1 ml of saline alone. These injections were repeated 
daily on the 25th, 26th and 27th gestational days and are designated 
for convenience as the standard regimen. 
At the 28th gestational day, at approximately the same time of 
day as mating occurred, the does were again weighed and in some cases 
venous blood was collected. This was accomplished by cutting the super-
ficial vein at the lateral aspect of the ear and allowing the blood to 
drip into a collecting tube. This blood was sent to the clinical bio-
I 
t 
chemistry laboratory at Loyola University's Foster McGaw Hosp~tal and 
evaluated by the automated SMA-12 test series. Following collection of 
blood, the does were killed by injecting 30 ml of air into the same 
vein which was used to collect blood. This procedure resulted in a 
massive air embolism and the rapid death of the animal. 
Immediately following death, the abdominal cavity of the animal 
was opened by a rapid mid-ventral incision. The fetuses were then 
obtained by a hysterotomy, removed from the amniotic sac and weighed. 
To prevent the fetuses from breathing, and thus becoming neonates, 
pressure was applied to the trachea, first by the thumb and then by 
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the rapid application of a ligature placed around the neck. 
In order to maintain uniformity between experiments, fetuses of 
corresponding uterine placement were used for each procedure whenever 
possible. The most lateral fetus of the right uterine horn was re-
moved first, as above, and the thorax opened by a mid-ventral incision. 
The entire upper and lower lobes of the right lung were removed, inde-
pendently chopped into approximately 1 mm cubes and fixed in 2% glutar-
aldehyde buffered to pH 7.2 with .2M Sorenson's phosphate buffer. The 
left lung was fixed in toto by immersion in 10% buffered formalin. 
Simultaneously, the fetuses of the left uterine horn were removed, as 
above, and their lungs and livers frozen immediately by immersion in 
liquid nitrogen. In some cases the right lower lobe of the most lat-
eral fetus in the left uterine horn was used for scintillation auto-
radiography as explained below. 
Fetal lung tissue obtained on the 28th gestational day bas 
' 
studied using all of the procedures described below under thei, heading 
"Tissue Processing and Data Procurement" and constitute the bulk of 
the project. 
In some cases portions of maternal lung were removed and fixed 
in 10% buffered formalin for paraffin embedding. In one case portions 
of various maternal organs, including liver, kidney, gastrointestinal 
tract, uterus and others, were similarly removed and fixed. 
Standard Regimen -- 31 days 
In two experiments (Table I) a delay was allmved between the 
43 
maternal administration of pilocarpine and sacrifice of the animal, 
in order to determine whether pilocarpine treatment resulted in any 
long: term deleterious effects on the fetal lung and its maturation. 
The does were injected using the standard regimen, that is with 5 mg/kg 
pilocarpine or with saline on the 24th through the 27th gest;ational 
day. Subsequently these does were maintained without additional treat-
ment until the 31st gestational day, at which time the experiments 
were terminated. Fetal lung tissue obtained at 31 days was fixed in 
2% glutaraldehyde and analyzed using electron microscopy as well as 
electron microscopic stereology (see below). In addition, fetal and 
maternal lung tissue were fixed in formalin for paraffin embedding. 
Time-Course Studies 
In order to establish a time-course of the effects of maternal 
administration of pilocarpine, treatment was begun as with the standard 
regimen but the animals were killed before the 28th gestatiorial day. 
i 
I 
Pregnant does received pilocarpine or saline injections, beginning 
with the 24th gestational day, and were sacrificed at the 25th, 26th 
and 27th gestational day. Therefore, these does were treated for 1, 2 
or 3 days at the time of sacrifice (Table I). Additional controls 
included fetuses of 29 and 30 days gestation obtained from non-injected 
does. Again, fetal lung tissue was analyzed by electron microscopy 
and stereology as explained below. 
Single Injection Studies 
Pilot studies early in the project included experiments dealing 
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with the short term effects of maternal administration of pilocarpine 
on the fetal lung. At different days of gestation, various strength 
doses (10-80 mg/kg) were administered to the pregnant females, which 
were then sacrificed at various times post-injection (2-24 hours). 
These experiments are sunnnarized as part of Table I. Fetal :lungs 
obtained in these studies were examined by routine light and electron 
microscopy. 
Injection of Fetuses In Utero 
In two cases pilocarpine was injected directly into the fetus, 
thus by-passing the maternal route used in the remainder of the 
experiments. In order to accomplish this, pregnant does (one at the 
26th day and one at the 27th day) were given general anesthesia and 
a laparotomy was performed. The fetuses of the left uterine horn were 
injected intraperitoneally, through the uterine wall and amniotic sac, 
with 10 mg pilocarpine in 0.5 m1 of 0.9% saline. Fetuses of the right 
I 
horn were given 0.5 ml of saline alone, in the same manner. the abdo-
I 
minal incision of the doe was then sutured, and following the intra-
muscular injection of antibiotic the does were allowed to recover. At 
24 hours post-injection the doe was killed and lung tissue obtained 
from the fetuses as explained above. This tissue was then analyzed 
using electron microscopy. 
Tissue Processing and Data Procurement 
Glycogen Determination 
The lungs and livers of the 28 day fetuses which were frozen by 
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immersion in liquid nitrogen were used for the determination of gly-
cogen content. This was accomplished using a modification of the method 
of ~urat and Serfaty ('76). The entire lung or liver to be analyzed 
was first weighed, and then homogenized with 3 ml of citrate buffer 
(pH 4.2) in a Waring blender. For free glucose determination 0.1 ml 
of the homogenate was removed. The remainder was incubated at 37°C 
for two hours with the enzyme amyloglucosidase. This enzyme splits the 
glycogen present in the tissue into free glucose residues. Following 
the incubation period 0.1 ml of the homogenate was removed and, along 
with the 0.1 ml removed prior to incubation, a blank and a standard 
glucose solution were analyzed for glucose. Samples were deproteinated 
by adding 1.1 ml of water, 0.4 ml of barium hydroxide and 0.4 ml zinc 
sulfate. They were then centrifuged and 0.5 ml of the supernatant was 
removed. To this was added 2 ml of PGO (peroxidase and glucose oxi-
dase) enzyme solution and 0.1 ml of the color reagent 0-dianisidine. 
The mixtures were then incubated at 37°C for 30 minutes and t~e absorb-
I 
ency readings were obtained using a Gilford 250 spectrophotometer. By 
using a standard curve the concentration of glucose in each sample was 
ascertained. Subtracting the free glucose value obtained from. the 
\ 
original homogenate (prior to incubation) from that obtained following 
incubation with amyloglucosidase, a value of the amount of glucose due 
to glycogen breakdown was obtained. The amount of glycogen in each 
lung or liver was expressed as mg/gm tissue. 
Paraffin Embedding 
The lungs which were fixed in toto in formalin were processed for 
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paraffin embedding using an Autotechnicon Model 2A automated tissue 
processor timed as follows: 80% ethanol, .5 hr; 95% ethanol, 3 changes 
of l,hr each; 100% ethanol, 3 changes of 1 hr each; toluene, 2 changes 
of 1 hr each; liquid Paraplast (Scientific Products), 2 changes of 1 hr 
each. Following this the tissue was placed in a vacuum oven for 1 hr 
and then embedded in Paraplast. Sections were cut at 4-6 ~m on an 
American Optical rotary microtome and stained with either Harris hema-
toxylin and alcoholic eosin or Periodic acid-Schiff with (D-PAS) or 
without (PAS) diastase (malt U.S.P.) pretreatment. 
Electron Microscopy, 
Lung tissue placed in glutaraldehyde was allowed to fix over-
night in the original fixative solution. The following morning the 
tissue was washed in Sorenson's phosphate buffer for 4 changes of 
15 minutes each and then post-fixed in 1% phosphate buffered osmium 
tetroxide for two hours. The tissue was then rapidly dehydrdted as 
' follows: one 15 minute change in each of 50%, 70% and 95% ethanol; 
two 15 minute changes in 100% ethanol; two 15 minute changes in pro-
pylene oxide. They were then placed in a 1:1 mixture of propylene 
I 
oxide and Epon 812 mixture for 1 hour, in a 3:1 mixture of the same 
compounds overnight and then again overnight in a pure Epon 812 mix-
ture. The following morning the tissue was embedded in fresh Epon 812 
utilizing standard BEEM capsules. The Epon 812 mixture used through-
out this project was prepared volumetrically as follows: Epon 812, 
214 ml; DDSA, 216 ml; NMA, 71 ml; DMP-30, 7.5 ml. This mixture was 
stored at -40°C until used. Polymerization was carried out at 40°C 
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for one day and then at 60°C for two days. 
Using a Sorvall MT-1 ultramicrotome and glass knives, 1 ~m 
sections were cut from the blocks, mounted on glass slides and stained 
with toluidine blue. These sections were used for orientation and 
trimming of the blocks for thin sectioning and, in some cases, for 
ligl1t microscopic morphometric analysis as explained below. Using 
the same microtome and a diamond knife, thin sections were cut from 
the trimmed blocks at a thickness of 600-800 nm. These sections were 
mounted on 200 or 300 mesh copper grids and stained with 5% uranyl 
acetate and Reynold's lead citrate ('63). Ultrastructural examination 
was then carried out using an RCA EMU-3H electron microscope with an 
accelerating voltage of 100 KV. 
Light Microscopic Morphometric Analysis 
The 1 ~m Epon sections were used for the light microscopic 
i 
' 
morphometric analysis of the numeric distribution of mature, pr well 
I 
differentiated, type II alveolar epithelial cells in the lungs of 
fetuses obtained at the 28th gestational day from control and pilo-
carpine treated groups. Sections of randomly selected blocks were 
photographed at 400X magnification on a Zeiss Photomicroscope II using 
Kodak PCF-3 film. The transparencies thus obtained were used in a 
blind study where the slides were viewed randomly in a Kodak rear 
screen projector. The number of cells of any type, as well as the 
number of well differentiated type II cells in the unit area of the 
2 transparency (.035 mm ) were recorded. Cells of airways other than 
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alveoli (bronchi, bronchioles, etc.) or cells of blood vessels larger 
than capillaries were not included in the cell count. The area oc-
cupied by these omitted cells was determined using a standard grid 
pattern and subtracted from the unit area of the slide. The results 
of this study were expressed as type II cells/unit area and"type II 
cells/1,000 lung parenchymal cells. 
Electron Microscopic Morphometry and Stereology 
In 28-day fetuses treated with the standard regimen a morpho-
metric analysis of the lamellar inclusion bodies and multivesicular 
bodies within the type II cells was undertaken. Randomly selected 
blocks of upper and lower lobe lung tissue from six fetuses in each 
group (all from different litters) were thin sectioned and evaluated 
in a blind study. All alveolar epithelial cells which could be ident-
ified as type II cells were photographed at a standard magnification 
of 5,800X. Identification of type II cells at this gestatiodal age 
I 
was based on cuboidal shape, presence of microvilli and, most! impor-
tantly, the presence of at least one lamellar inclusion body. This 
process resulted in photographs of at least 120 cells from eac~ of the 
upper and lower lobes of the two groups (control and pilocarpine 
treated). In these photographs, enlarged to a final magnification of 
20,000X, the number of inclusion bodies and multivesicular bodies in 
each cell was recorded. In addition, the size of each lamellar inclu-
sion body, measured at its maximum diameter, was recorded. 
In all cases where electron microscopic stereology was undertaken 
49 
20-25 electron micrographs of each of the upper and lower lobes of 
both control and pilocarpine treated fetuses were obtained. For the 
28-d,ay fetuses the electron micrographs were selected at random from 
those used for morphometry as explained above. For the 31-day fetuses 
and the time-course study they were obtained in a similar fashion to 
those of 28-day fetuses. However, cells of fetuses with gestational 
age less than 28 days were not restricted to being type II cells 
specifically. Due to a distinct lack of recognizable type II cells, 
according to the identification criteria used at gestational age 28-31 
days, any cuboidal cell lining the alveolar space was photographed and 
used for stereologic analysis. Following stereologic analysis a tally 
was made of all cells which contained lamellar inclusion bodies in any 
volume density. The latter cells were considered type II cells and 
the percent of all cuboidal cells which these constituted was calcu-
lated and recorded. 
I 
I 
Stereologic analysis was performed in order to determiri,e the 
volume density of major cell components, and employed the methods of 
Weibel ('73). The cell components which were analyzed in the present 
study included glycogen, lamellar inclusion bodies, rough endoplasmic 
reticulum, Golgi apparatus and mitochondria. A transparent acetate 
sheet imprinted with a 1/4 inch grid (Xerox Corp. #8R377) was placed 
over each photograph in turn and held securely in place. In this 
study the points of intersection of the grid lines were used as the 
reference points. Point "hits" then, were defined as the line inter-
sections which fell over a given cell structure. 
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Point "hits" were tallied for each of the structures of interest, 
as well as fo~ all other cytoplasmic components, taken as a group. 
Thus, any point not falling over one of the cell structures of interest 
was grouped under "other" and added to the point "hits" which did fall 
over one of the structures named above. This was done in order to 
obtain a total for all point "hits" falling over anything in the 
cytoplasmic portion of the cell. Point "hits" falling over the nu-
cleus were not included. 
Using the equation Point Intercept/Point Total (P./P ) =Point 
l.. t 
Density (P ) = Profile Density on a test area (A ) = Volume Density p a 
(V) (Glagoleff, '33; Chalkley, '43; Weibel, '63, '72), volume densi-
v 
ties were obtained for each of the structures of interest. 
Scintillation Autoradiography 
In some cases portions of lung approximately 1 mm x 5 mm 
were removed from the periphery of the right lower lobe of th'e most lat-
1 
' 
eral fetus in the left uterine horn for evaluation of cell division 
using scintillation autoradiography. The pieces of lung were rapidly 
placed in culture media (Gibco minimum essential media, 20% fetal calf 
serum) containing 5~Ci/ml tritiated thymidine (Amersham, specific 
activity 20 Ci/mmol). These were then maintained at 37°C, using a 
standard tissue culture incubator, for two hours. Following incubation 
the tissues were fixed in cold 2% phosphate buffered paraformaldehyde 
and were allowed to remain in the fixative overnight. The following 
morning they were washed through three changes of Sorenson's buffer. 
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Dehydration was then carried out in a graded methacrylate (Polysciences 
JB-4 catalyzed solution A, prepared as per kit instructions) series as 
follows: 50% JB-4, two changes of .5 hour each; 70% JB-4, two changes 
of .5 hour each; 95% JB-4, two changes of .5 hour each; 100% JB-4, two 
changes of 1.5 hour each, this step corresponding to infiltration. The 
tissues were then embedded in a 25:1 mixture of JB-4 catalyzed solution 
A to JB-4 solution B, as per kit instructions. To accomplish poly-
merization a block molding cup was used and covered with paraffin. 
Following a two day polymerization period sections were cut at 1-1.5 ~m 
using a DuPont JB-4 microtome and glass knife, and mounted on glass 
slides. These slides were then coated, using standard techniques 
(Rogers, '67) with Kodak NTB-3 nuclear track emulsion. The emulsion 
was diluted 1:2 with distilled water, giving a very thin emulsion layer 
of approximately 1 ~m thickness. The emulsion was then allowed to 
dry on a cooled metal plate for one hour and the slides were dipped 
I 
for 10 seconds in a scintillation cocktail which was previously pre-
' pared by adding 10 grams of Packard Permablend I premixed scintillator 
to 1,000 m1 of dioxane. Permablend I consists of 90% PPO (2,5-diphenyl-
oxazole) and 9% dimethyl POPOP ([1,4-bis-2(4-methyl-5-phenylox~zolyl)-
benzene]). The slides were then allowed to dry, placed in light proof 
boxes and allowed to expose for three days at 4°C. The exposure time 
was able to be shortened to three days because in scintillation auto-
radiography the S-particles emitted by the tritium, in addition to 
causing direct exposure of emulsion grains, also cause photon release 
from the scintillator, which further exposes the emulsion. 
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The autoradiographs were then developed for two minutes in Kodak 
Dektol developer diluted 1:2 with distilled water and fixed in Kodak 
Rapi~ fixer for 5 minutes. Following a 15 minute running water wash 
the slides were rinsed through a graded ethanol series, to remove the 
residue of the scintillation mixture, and stained lightly with Toluidine 
blue (stock solution diluted 1:10 with water). The autoradiographs 
were then photographed at 400X magnification using a Zeiss Photomicro-
scope II and Kodak PCF-3 film. Only the outer 0.2 mm of each tissue 
section were photographed since anoxic changes (including nuclear 
pyknosis) were frequently observed in the central portions of the 
tissue fragments. The transparencies thus obtained were viewed ran-
domly in a rear screen projector. The numbers of labelled and unlabel-
led alveolar epithelial cells and interstitial cells in each slide 
were recorded so as to obtain labelled cell indices (labelled cells/ 
1,000 cells) for both types of cells. 
Statistical Analyses 
All data which required statistical analysis were analyzed using 
the Student's t-test. This was accomplished using a Texas Instruments 
\ 
data terminal linked to Loyola University's main computer via an 
Anderson Jacobsen acoustic direct audio coupler. The program utilized 
was catalogued as "SNAP" or Statistical Numerical Analysis Package 
and is listed on the "Public" file of Loyola's available programs. 
RESULTS 
Injection of Fetuses In Utero 
Light microscopic examination of paraffin sectioned fetal lung 
revealed no discernable differences between that of fetuses injected 
with pilocarpine in utero and those injected with saline in a like 
manner (figs. 1, 2). However, fetal lung in both groups appeared 
more mature than lung obtained from non-operated control fetus'es of 
the same gestational age (fig. 9). Maturational changes observed in 
fetuses injected in utero included a loss of glycogen, thinner septa 
and the appearance of some surfactant material in the alveolar spaces 
(figs. 1, 2). 
Electron microscopic studies corroborated these findings in 
that there was also ultrastructural evidence of apparent maturational 
I 
changes present in the lungs of fetuses injected in utero witp either 
I 
I 
saline or pilocarpine. The type II epithelium of both groups' con-
tained substantially less glycogen than that of non-operated controls 
and there appeared to be a stimulation of surfactant synthesis~ as 
evidenced by the increased number of lamellar inclusion bodies and 
prominence of other organelles c~nstituting the secretory apparatus 
of the type II cells (figs. 3, 4). Although these changes were pre-
sent in both groups, ultrastructural evidence indicated that the ef-
fects were accentuated in the pilocarpine-treated group. There was 
no evidence of changes in the type I alveolar epithelial cells in 
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either pilocarpine or saline injected group, when compared to those 
of non-operated controls. 
Single Injection Studies 
Following a single injection of pilocarpine the pregnant does 
exhibited all the signs expected from the administration of a para-
sympathomimetic agent. Salivation, lacrimation and diarrhea began 
approximately 15 minutes post-injection and persisted for about three 
hours. In those experiments utilizing higher doses of pilocarpine 
(i.e. 20-40 mg/kg) these effects were more pronounced and persisted 
for a longer time period. In all cases the does appeared mildly dis-
tressed and their breathing was somewhat labored. Light microscopy, 
however, revealed no apparent deleterious changes in lung obtained 
from any of these does at various time intervals (2-24 hours) after 
pilocarpine injection. Electron microscopic evaluation revealed 
changes in the type II pneumocytes of these does which indicated a 
I 
stimulation of the exocrine secretory function of these cells~ These 
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changes, which were particularly apparent at two hours post-injection, 
included the presence of dilated rough endoplasmic reticulum and in-
creased lamellar inclusion bodies (compare figs. 5, 6). 
Fetal lung from cases which utilized varying, single, doses of 
pilocarpine (10-40 mg/kg), varying post-injection sacrifice times 
(2-24 hours) and varying gestational ages (28-30 days) was also ex-
amined. Although there was some effect in all cases, the results of 
these experiments indicated more marked effects of single pilocarpine 
injections in cases involving higher doses, later gestational ages 
and shorter post-injection sacrifice times. Although light microsco-
pic examination in these cases revealed fetal lung virtually indis-
tinguishable from controls, electron microscopy indicated changes in 
type II cells of these pilocarpine-treated fetuses which suggested 
an increased secretion of surfactant. These changes resembled those 
observed in adult lung, including increased numbers of lamellar in-
clusion bodies as well as increased multivesicular bodies and rough 
endoplasmic reticulum (compare figs. 7, 8). 
Standard Regimen--28 days 
Experiments involving 28-day fetuses obtained from mothers 
receiving daily injections of pilocarpine on the 24th through the 
27th gestational day were performed in order to evaluate the effect 
of prolonged pilocarpine stimulation. These constituted the bulk 
of the present study. 
Maternal Effects 
As in the single injection studies, following each pilocarpine 
injection the pregnant does exhibited all the signs of parasympathe-
tic stimulation. Food intake for both the control and pilocarpine-
treated does was standardized and water intake was comparable between 
the two groups, averaging 360 + 55 ml per day in the pilocarpine-
treated group and 280 ± 43 ml in controls. These values, while some-
what higher in the pilocarpine-treated group, were not statistically 
different. During the four day injection period the pilocarpine-
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treated does exhibited a mild weight loss (average of 3.8%) compared 
to a slight weight gain in control animals during the same period 
(ave~age of 2.4%). This difference is thought to be due to diarrhea, 
since food and water intake was essentially the same in control and 
pilocarpine-treated animals. Furthermore, the results of the SMA-12 
tests on the serum of the two groups revealed no significant differ-
ences in any of the twelve parameters tested (table II). 
By light microscopy the lungs of the does which received pilo-
carpine exhibited some areas of minor atelectasis, but no other 
changes were observed. Additionally, in one case a survey of many 
organs, including uterus, liver, gastrointestinal tract and kidney, 
was performed by light microscopy which disclosed no apparent abnorm-
alities in any organ from the pilocarpine-treated doe. 
Fetal Effects 
Fetuses of control and pilocarpine-treated mothers (her~after 
for convenience referred to as control and pilocarpine-treated 
fetuses) were comparable grossly, with an occasional dwarf or dead 
fetus being found in each group. The average weight of pilocarpine-
treated fetuses from eight representative does was 26.95 g (± 1.97 
SEM) as compared with 35.42 g (±·1.42) for control fetuses. These 
values were significantly different ( p <0.001). Grossly the lungs 
of pilocarpine-treated fetuses appeared normal, as did all other 
organs. 
Light microscopic evaluation of paraffin embedded fetal lungs 
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TABLE II 
RESULTS OF SMA-12 TEST SERIES ON MATERNAL SERUM 
Test Control Pilocarpine 
Calcium (mg%) 11.38 + 0.46 12.68 + 0.08 
Inorganic Phosphates (Mg% P) 3.45 + 0.37 2.82 + 0.19 
Glucose (mg%) 130.00 + 6.18 124.00 + 1.81 
Blood Urea Nitrogen (BUN) (mg%) 19.43 + 4.05 16.57 + 0.44 
Uric Acid (mg%) 0.57 + 0.03 0.57 + 0.05 
Cholesterol (mg%) 27.43 + 2.00 25.33 + 3.13 
Total Phosphorus (gm%) 5.00 + 0.20 5.15 + 0.08 
Albumin (gm%) 0.68 + 0.02 0.671 + 0.02 
Total Bilirubin (mg%) 0.23 + 0.04 0.26' + 0.03 
~-
' 
Alkaline Phosphatase (mU. /ml) 27.71 + 4.90 20.66 + 1. 74 
LDH (mU. /ml) 181.85 + 23.00 294.00 + 71.7 
SGOT (mU. /ml) 36.00 + 4.43 38.33 + 13.56 
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revealed that the lungs of pilocarpine-treated fetuses gave an over-
all impression of an advanced maturational stage, when compared to 
thos~ of controls. This impression was based on general configuration 
and alveolar septal thickness (compare figs. 9, 10). Examination of 
PAS-stained paraffin sections showed a marked decrease in the amount 
of PAS-positive material in the lung cells of pilocarpine-treated 
fetuses. In slides stained with PAS after diastase pre-treatment 
(D-PAS) no difference was noted between pilocarpine and control fetal 
lungs, indicating that the difference originally noted in PAS staining 
was due to glycogen content. The validity of this observation was 
substantiated by the biochemical determination of glycogen content. 
The results of this study (table III) indicated a significant decrease 
in the glycogen content of the lungs of pilocarpine-treated fetuses, 
when compared with controls. There was, however, no significant dif-
ference in the glycogen content of the fetal livers between the two 
groups, which would indicate that the difference observed in 1the lungs 
I 
I 
I 
was not due to a generalized depletion of glycogen stores in the pilo-
carpine-treated group. 
Light microscopic examination of toluidine blue-stained 1 ~m 
thick sections of Epon embedded fetal lung reinforced the impression 
of an overall appearance of increased lung maturation in the pilo-
carpine-treated group, again based on alveolar configuration and 
septal thickness. In addition, since the resolution of individual 
cells was possible in these plastic sections, it was observed that the 
alveoli of the pilocarpine-treated fetuSes appeared, for the most part, 
to be lined by cells which were fairly well differentiated into type I 
CONTROL 
PILOCARPINE 
TABLE III 
GLYCOGEN CONTENT (mg/gm tissue) 
Number of Number of 
Litters Fetuses 
5 17 
7 25 
LUNG LIVER 
4.11 + 0.33 16.98 + 2.03 
2.65 + 0.13 14.98 + 1.30 
p < .001 n:. s. 
i 
I 
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and type II cells (fig, 11). In contrast, the alveoli of control 
fetal lungs were lined by many apparently immature cuboidal cells, as 
well ;as type I and type II cells (fig. 11). 
These findings were confirmed by light microscopic morphometric 
analysis of the distribution of mature type II cells in these lungs. 
This study revealed a significant increase in the number of mature 
type II cells in the lungs of pilocarpine-treated fetuses, both .per 
2 
unit area of section (0.035 mm ) and per 1,000 lung cells of any kind 
(fig. 12). Such an analysis was possible since mature, or well dif-
ferentiated type II cells are readily recognizable in 1 ~m thick sec-
tions by their size, shape, position and, most importantly, the 
presence of lamellar inclusion bodies (fig. 11). 
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Ultrastructural examination confirmed that the alveoli of 28-day 
control fetal lungs were lined by numerous immature cuboidal cells, as 
I 
well as type I and type II cells in various stages of differeptiation 
I 
and maturation (fig. 13). Immature cuboidal cells are characterized 
by very large accumulations of glycogen and show little indication of 
differentiation into either type I or type II cells (fig. 26). In 
addition, the alveolar epithelial cells which had already differen-
tiated into type I or type II cells appeared, in general, at a rela-
tively immature stage of maturation. The nuclei of type I cells in 
these control fetal lungs were often surrounded by relatively abundant 
cytoplasm, indicative of an immature state. ~.Jhile the cytoplasmic 
extensions of these cells in some areas formed blood-air barriers, 
these extensions were frequently thick and contained, in addition to 
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accumulations of glycogen, mitochondria and rough endoplasmic reticu-
lum (fig. 15). In addition, the nuclei of pulmonary capillary endo-
thelia! cells were often found positioned directly adjacent to devel-
oping type I cell cytoplasmic extensions, resulting in very thick, 
immature, blood-air barriers. 
The majority of the type II cells present in 28-day controls 
were characterized by abundant glycogen, a poorly developed secretory 
apparatus and relatively few multivesicular bodies and lamellar inclu-
sian bodies (figs. 17, 19). The inclusion bodies which were present 
in these cells often possessed a homogenous core surrounded by rela-
tively few, or less intensely stained, lamellae (figs. 17, 19). 
The alveolar epithelium of pilocarpine-treated fetuses demon-
strated striking ultrastructural differences from controls in many 
respects. The cells lining the alveoli of these fetuses were, in the 
vast majority, well differentiated into type I or type II ceJ!ls, with 
i 
immature cuboidal cells being extremely rare (fig. 14). The 6ost pro-
minent change in these lungs was a striking reduction in the glycogen 
content of alveolar epithelial cells, with many of these cells.con-
taining virtually no glycogen. 
Type I cells of pilocarpin~-treated fetuses appeared, in general, 
to be at a more advanced stage of maturation than did those of con-
trols. The nuclei were surrounded by a thin rim of cytoplasm con-
taining sparse organelles and virtually no glycogen. The cytoplasm 
of these cells was most often attenuated to form mature, very thin, 
blood-air barriers (fig. 16). 
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When glycogen was present in the type II epithelial cells of 
pilocarpine-treated fetuses, it was usually in relatively small 
amo~ts and often associated with surfactant material (fig. 20). 
Additional findings in these cells involved maturational changes indi-
cative of an increased activity of the secretory apparatus which 
produces pulmonary surfactant. These findings included an increase or 
dilatation of the rough endoplasmic reticulum associated with the pre-
sence of relatively numerous multivesicular bodies and large, densely 
osmiophilic, lamellar inclusion bodies which tended to aggregate to-
ward the apex of the cell. The majority of these inclusion bodies 
possessed many well defined lamellae which, according to Kikkawa's 
classification ('68), would represent more mature forms (figs. 18, 20). 
Lamellar inclusion bodies in type II cells of pilocarpine-treated 
fetuses were also seen in the process of being, apparently, secreted 
into the alveolar space (fig. 18) with greater frequency than in con-
trols, where this was rarely observed. I Also observed more often in 
I 
pilocarpine-treated fetuses were membranous whorls and segments of 
tubular myelin within the alveolar space (fig. 16). These are indi-
cative of surfactant lipids and as such are the end-result of the 
I 
secretion of lamellar bodies from the type II cells, as mentioned 
above. The remainder of the organelles within the type II cells were 
much the same in the two groups, with the exception of the Golgi ap-
paratus, which appeared prominent, or multiple, with greater frequency 
in the type II cells of pilocarpine-treated fetuses. 
The ultrastructural morphometric study dealing with the size and 
numerical distribution of lamellar inclusion bodies, as well as the 
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number of multivesicular bodies within the type II cells of the two 
groups substantiated the above interpretations of the electron micro-
scopic findings. The results of this study (table IV) indicated that 
both the number of lamellar inclusion bodies per type II cell and the 
average size of the lamellar inclusion bodies were increased signifi-
cantly in the pilocarpine-treated group when compared to controls. 
In addition, the number of multivesicular bodies present in the type 
II cells of pilocarpine-treated fetuses, expressed as number/ ten 
type II cells, was also increased significantly over control values. 
Further quantification of the ultrastructural differences observed 
between type II cells of the two groups was obtained by stereologic 
analysis. The results of this study, expressed as percentages of 
total cytoplasmic volume, are listed in table V. These data indicated 
that the cytoplasmic volume density of lamellar inclusion bodies, 
rough endoplasmic reticulum and Golgi apparatus were increased signi-
I 
ficantly in the type II cells of pilocarpine-treated fetuses.! The only 
' 
exception was the volume density of the Golgi apparatus in the type II 
cells of the right lower lobe. In this case the mean value for pilo-
carpine-treated fetuses was higher than that of controls, but this 
elevation was not statistically significant. In addition to these 
increases in cytoplasmic components contituting the secretory appara-
tus and its product, there was a significant decrease in the volume 
density of glycogen in the type II cells of pilocarpine-treated 
fetuses. There was no difference in the values obtained for the 
volume densities of mitochondria in the two groups. 
TABLE IV 
RESULTS OF ELECTRON MICROSCOPIC MORPHOMETRIC ANALYSIS ON TYPE II CELLS OF 28-DAY FETUSES 
Parameter 
Inclusion Bodies/Type II Cell 
Upper Lobe 
· Lower Lobe 
Size of Inclusion Bodies (~m) 
Upper Lobe 
Lower Lobe 
Multivesicular Bodies/ 
Ten Type II Cells 
Upper Lobe 
Lower Lobe 
(STANDARD REGIMEN) 
Control 
3.95 + .48 
3.19 + .39 
.692 ± .024 
.674 + .034 
1.93 + . 45 
-1.47 + .29 
Pilocarpine 
5.36 + .37 
5. 02 + .40 
• 813 + .017 
.836 + .031 
3.02 + .43 
3. 43 + . 78_. 
p 
<.05 
<.01 
<,001 
<.005 
<,05 
<.05 
TABLE V 
RESULTS OF ULTRASTRUCTURAL STEREOLOGY OF 28-DAY (STANDARD ~EGIMEN) 
FETAL TYPE II CELLS 
Expressed as Percent Cytoplasmic Volume 
Structure Control 
Lamellar Inclusion Bodies 
Upper Lobe 
Lower Lobe 
Glycogen 
Upper Lobe 
Lower Lobe 
Rough Endoplasmic 
Upper Lobe 
Lower Lobe 
Golgi Complex 
Upper Lobe 
Lower Lobe 
Mitochondria 
Upper Lobe 
Lower Lobe 
7.2 + 0.9 
5.6 + 0.6 
27.3+1.7 
34.3 + 2.2 
Reticulum 
7.8 + .6 
5.9 + .6 
2.0 + .4 
2.6 + .5 
8.0 + .5 
6.4 + . 7 
Pilocarpine 
10.6 + 1.0 
12.9 + 1.2 
13.7 + 1. 7 
17.6 + 1.7 
10.9 + .8 
14.3 + 2.7 
3.5 + .6 
3.1 + • 7 
8.5 + .7 
7.8 + .4 
p 
<.025 
<.001 
<.001 
<.001 
<.005 
<.005 
<.05 
N.S. 
N.S. 
N. S. 
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Electron microscopic stereologic analysis of type II cells from 
29, 30 and 31-day control fetuses was undertaken in order to ascertain, 
by cqmparison, the overall maturational change in the type II cells, 
in terms of gestational days, of 28-day pilocarpine-treated fetuses. 
The volume density of lamellar inclusion bodies in the pilocarpine-
treated group was not significantly different from values obtained in 
29 or 30-day control fetuses (fig. 25). The glycogen content of the 
type II cells of 28-day pilocarpine-treated fetuses was significantly 
higher than that of 29, 30 or 31-day-controls. Rough endoplasmic 
reticulum in these cells was not significantly different from 31-day 
controls, while the volume density of Golgi apparatus did not differ 
significantly from controls of 30-days gestation (fig. 25). 
Scintillation Autoradiography 
Using scintillation autoradiography, adequate labelling of cells 
which had incorporated the 3H-thymidine was obtained after oJly three 
days of exposure. Cells were considered labelled if there we~e at 
least five emulsion grains over the nuclei. As shown in figure 21, 
the labelling obtained with this method was quite distinct and,well 
localized over individual nuclei, while background grain exposure was 
minimal. Moreover, the use of 1 ~m thick plastic sections, instead 
of thicker paraffin sections, enabled the identification of intersti-
tial and alveolar epithelial cells, based on position, size and histo-
logic features (fig. 21). 
The blind study of the labelled cell index of alveolar epithe-
lium revealed that the number of labelled epithelial cells was 
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decreased significantly in the pilocarpine-treated group when compared 
to controls (fig. 22). In addition, the number of labelled intersti-
tial, cells was also significantly lower in the pilocarpine-treated 
group than in controls (fig. 22). 
Standard Regimen--31 days 
Maternal lung tissue obtained at the 31st gestational day from 
does which had been treated with the same standard regimen (on days 
24-27) as those killed at 28 days was studied by light microscopy. 
Examination of paraffin sectioned lung stained with H&E, PAS or D-PAS 
revealed no noticable differences from adult controls obtained at the 
same gestational age. Fetal lung was similarly studied and again 
showed no differences between control and pilocarpine-treated groups. 
' Fetal lung of both groups appeared mature, with thin septa, many 
blood-air barriers and very little, if any, glycogen within alveolar 
epithelium or cells of the septa. In addition, some alveola~ spaces 
I 
of both groups contained D-PAS positive granular material whi!:h is 
indicative of surfactant secretion. 
Electron microscopic comparison of 31-day fetal lung demonstra-
ed no observable damage in the lungs of fetuses which had been treated 
with pilocarpine on gestational days 24-27. Lung parenchyma appeared 
normal and comparable to controls and there was no evidence of any 
damage to type II alveolar epithelial cells (compare figs. 23, 24). 
Stereologic analysis revealed that the type II cells of pilocarpine-
treated fetuses contained a significantly greater volume density of 
lamellar inclusion bodies than those of controls (fig. 25). Addition-
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ally, although little remained in any cell of either group at 31 days, 
the amount of glycogen present in the type II cells of pilocarpine-
treated fetuses remained significantly lower than control values (fig. 
25). The volume densities of rough endoplasmic reticulum and Golgi 
complex were comparable to controls, however, the volume of'mitochon-
dria was significantly decreased in the pilocarpine-treated group. 
Time-Course Studies 
Fetal lung obtained from control and pilocarpine-treated fetus-
es at gestational ages 25, 26 and 27 days was examined by electron 
microscopy and the cuboidal cells lining the alveolar space were ana-
lyzed by electron microscopic stereology. 
At the 25th gestational day the epithelium lining the control 
fetal lungs was quite immature, the cuboidal cells being 50% immature 
cuboidal cells (table VI). These cells contained much glyco9en and 
some organelles but showed no signs of differentiation (fig. 26). The 
I 
other 50% of the cuboidal cells photographed randomly for stereology 
were classified as type II cells since they contained very immature 
forms of lamellar inclusion bodies or, occasionally, a single multi-
vesicular body. Stereologic analysis indicated that the cuboidal 
cells, as a group, contained roughly 34% (volume density of cytoplasm) 
glycogen and barely 0.3% inclusion bodies (fig. 25). Conversely, the 
cuboidal cells of pilocarpine-treated fetuses contained only 25% 
glycogen and 1.3% inclusion bodies, these values being significantly 
different from controls (fig. 25). In addition, these cells also 
TABLE VI 
PERCENT TYPE II CELLS OF SAMPLED CUBOIDAL CELLS 
Gestational Day 
25 
26 
27 
Control 
50% 
70% 
78% 
Pilocarpine 
65% 
75% 
100% 
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contained greater amounts of mitochondria, rough endoplasmic reticulum 
and Golgi complex (fig. 25). Cells classified as type II cells 
comprised 65% of the cuboidal cells which lined the alveoli of these 
fetuses (table VI). These cells were, like those of controls, 
relatively immature (fig. 27). 
Cuboidal cells present at the 26th gestational day in control 
fetal lungs contained slightly less glycogen and more lamellar bodies 
and Golgi than had those of 25 days (fig. 25). However, the ,overall 
appearance of the alveolar lining was still quite immature (fig. 28) 
even though 70% of the cells photographed were classified as type II 
cells (table VI). Stereology revealed that cuboidal cells of pile-
carpine-treated fetuses at 26 days had changed little from those of 
the previous day (fig. 25). Thus, at 26 days, the only structure 
which differed significantly from control values was the rough endo-
plasmic reticulum, which was significantly greater in the piLocarpine-
! 
' treated group (fig. 25). The majority (75%) of the cells lin:~ng 
! 
the alveolar space in this group were characterized as type II cells 
(table VI). 
The cuboidal cells lining the alveoli of 27-day controls were 
characterized by a large increase in lamellar bodies over the previous 
day, with a corresponding decrease in glycogen (fig. 25). Although 
78% (table VI) of the cuboidal cells were classed as type II cells, 
the inclusion bodies within these cells were characteristically im-
mature forms (fig. 30). 100% of the cuboidal cells which were ran-
domly photographed in pilocarpine-treated fetuses of 27 days gesta-
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tion were classed as type II cells (table VI). The volume density 
of lamellar inclusion bodies and rough endoplasmic reticulum were sig-
nific~ntly greater than in controls while there was significantly less 
glycogen (fig. 25). The lamellar inclusion bodies within these cells 
were, for the most part, well developed with distinct and numerous 
lamellae (fig. 31). 
DISCUSSION 
, The findings of this study indicate that maternal administration 
of pilocarpine results in stimulation of pulmonary surfactant synthe-
sis and secretion in the rabbit fetus and, in multiple doses, in 
accelerated differentiation of alveolar epithelial cells and matura-
tion of the fetal lung as a whole. Following pilocarpine administra-
tion on days 24 through 27 of gestation, morphologic correlates of 
increased maturat~on were apparent when fetuses were obtained on the 
28th gestational day. In addition, time-course studies indicated 
that some evidence of maturational changes in the lungs of pilocar-
pine-treated fetuses were apparent as early as the 25th gestational 
day. 
Based on electron microscopic examination of fetal rabbit lung, 
it was determined that the 28th gestational day was the best ~uited 
I 
I 
for the elucidation of changes occurring in the lungs of pilocarpine-
treated fetuses. Thus, the bulk of this study utilized fetuses of 
this gestational age. On the 28th day of gestation control fetal lungs 
were found to be relatively immature, in that the glycogen content of 
alveolar epithelial cells was high and cuboidal cells lining the al-
veoli contained relatively few lamellar inclusion bodies. These find-
ings are at variance to those of Kikkawa et al. ('68; '71) who observ-
ed no glycogen in alveolar epithelial cells on day 28 of gestation and 
concluded that the rabbit fetal lung was completely mature at this age. 
The reason for this discrepancy between the results of the present 
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study and those of Kikkawa is not clear, but may in part be related to 
differences in buffer or dehydration procedure used in tissue proces-
sing for electron microscopy. During the work involved in this 
project, it was observed that phosphate buffered glutaraldehyde and a 
rapid dehydration procedure are necessary for optimal preservation of 
the glycogen present in fetal rabbit alveolar epithelium. The common 
use of cacodylate buffer or prolonged dehydration results in a leach-
ing of glycogen out of the alveolar epithelial cells and the appear-
ance, by electron microscopy, of vacuoles indicating the location of 
previous glycogen deposits. 
In the present study pilocarpine was administered by a maternal 
route to avoid the possibility of stimulatory or maturational changes 
in the fetal lung, brought about simply by the trauma inherent in the 
operational procedure necessary to inject drugs to fetuses in utero. 
Results of the pilot experiments in which pilocarpine or saline were 
I 
i 
injected in utero at days 26 and 27 indicated that the lungs ',of fetus-
i 
es injected with only saline in this manner showed evidence of an 
acceleration of maturation when compared to similar fetuses of non-
operated mothers. These results confirm those of Robert et al~('75) 
who, using biochemical parameters, observed maturational changes in 
the surfactant system of fetuses·injected with saline in utero. The 
reason for this apparent stimulation is unclear; it may, however, be 
related to endogenous corticosteroid release or autonomic activation 
resulting from the surgical trauma to both the mother and fetus. 
An additional reason for administering the pilocarpine maternal-
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ly was that a primary aim of the study was to evaluate the effect of 
repeated stimulation of the fetal alveolar epithelium over a period of 
several days. This involved multiple administrations of pilocarpine 
and, since daily surgical procedures would be impractical, necessitat-
ed employing the maternal route for delivery of the pilocarpine. It 
was assumed that pilocarpine would cross the placental barrier since 
it is well documented that the vast majority of compounds with molecu-
lar weights less than 600 readily cross this barrier (Mirkin and 
Singh, '76) and pilocarpine HCl has a molecular weight of 244.7. 
Furthermore, when Corbet et al. ('76) administered pilocarpine direct-
ly to fetuses in utero, they observed evidence of pilocarpine stimula-
tion in the doe (salivation, lacrimation etc.) indicating that the 
drug had crossed the placenta from the fetus to the mother. Thus, it 
may be assumed that passage in the opposite direction, that is from 
the mother to the fetus, is also readily accomplished. 
I 
I 
Based on the study by Goldenberg et al. ('69) using adli,lt rats, 
i 
I 
initially 150 mg/kg pilocarpine was administered subcutaneously to the 
rabbits in the present study. Although this dose worked well in non-
pregnant adult rabbits, when administered to pregnant does it resulted 
in immediate convulsions and the rapid death of the animal. In the 
single injection experiments of the present study, doses of pilocar-
pine ranging from 10-80 mg/kg were employed and the larger of these 
doses, at times, also resulted in the death of the pregnant doe. Sub-
sequent experimentation revealed the dosage of 5 mg/kg to be optimal 
insofar as the pregnant females exhibited all the signs of parasympa-
thetic stimulation, but neither the doe nor the fetuses suffered any 
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increase in mortality. In addition, electron microscopic results 
from the single injection experiments indicated that this dosage was 
capable of stimulating the surfactant system of the fetus while pro-
clueing no apparent deleterious effects. 
Results of the SMA-12 test series which was performed on the 
serum of the pregnant does showed no significant differences between 
pilocarpine and saline groups, indicating that pilocarpine administra-
tion had no serious deleterious effects on the health or well_being 
of the animals. This was substantiated by the light microscopic 
survey of various organs of a pilocarpine-treated doe which revealed 
no abnormalities. Data obtained in this study did, however, reveal 
that the body weight of the pilocarpine-treated fetuses was decreased 
somewhat compared to controls. The reason for this reduction in 
weight is unclear. However, it is apparently not directly related to 
malnutrition since the food intake and blood glucose level of the 
I 
mother, as well as fetal liver glycogen, were not reduced from control 
values. Similar weight losses have been previously described in 
cortisol-treated rabbit fetuses (Motoyama et al., '71). Furthermore, 
Kotas et al. ('71) have demonstrated that the maturational stage of 
the lung is independent of body size in fetal rabbits; in fact, they 
observed that, within a given litter, smaller fetuses often had more 
mature lungs than larger littermates. 
Light microscopic observations of the lungs of 28-day pilocar-
pine-treated fetuses were consistent with an acceleration of matura-
tion, as judged by general architecture, septal thickness and, in PAS 
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stained sections, glycogen content. Similar parameters have been em-
ployed by many investigators involved in the study of maturational 
changes brought about pharmacologically (Kikkawa et al., '71; Wu et 
al., '73). In the present study, however, in order to substantiate 
the reduction in glycogen content observed morphologically, a bioche~ 
ical determination of glycogen content was employed. This method 
yielded data which agreed with the morphologic observations while also 
indicating that, since fetal liver glycogen was not significantly 
reduced in the pilocarpine-treated group, the reduction in glycogen 
content of alveolar epithelial cells in these fetuses was due to 
increased maturation, not malnutrition. 
Data obtained through light microscopic morphometric analysis 
demonstrated a significant increase in the number of mature, or well 
differentiated, type II cells per unit area as well as an increase 
relative to the total number of lung cells. It is of interest that 
I 
Kauffman ('77), using similar morphometric techniques, obtained 
I 
\ 
results much like those of the present study in an investigation of 
maturational changes in the lungs of fetal mice following maternal 
administration of dexamethasone, a glucocorticoid. Based on these 
findings Kauffman concluded that the alveolar epithelium in her exper-
imental group underwent accelerated differentiation following dexa-
methasone administration. The results of the present study suggest 
that pilocarpine administration causes a shift away from immature 
cuboidal cells and toward differentiation into mature type II cells, 
capable of active synthesis and secretion of surfactant. 
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Electron microscopic examination of the lungs of 28-day pilo-
carpine-treated fetuses revealed ultrastructural differences from 
controls which indicated increased maturation of the alveolar epithe-
lium. The observed epithelial changes are similar to those described 
in glucocorticoid (Kikkawa et al., '71) or thyroxine (Wu et !al., '73) 
treated fetuses, as well as in other studies employing pharmacologic 
means of increasing the maturation of the fetal lung (for review see 
Avery, '75). In the present study quantification of these changes was 
aided by the use of ultrastructural morphometry, which indicated that 
the number and size of lamellar inclusion bodies, as well as the 
number of multivesicular bodies, were increased significantly in the 
pilocarpine-treated group. In order to eliminate possible bias due 
to differences in cell size or lamellar body distribution, as well as 
to quantify other cell structures, stereologic morphometry was per-
formed. The goal of this method was to determine the cytoplasmic 
I 
volume densities of the various cell components which have been esta-
I blished as playing a role in the synthesis and secretion of pulmonary 
surfactant in the fetus. These structures include glycogen, lamellar 
inclusion bodies, mitochondria, rough endoplasmic reticulum and Golgi 
apparatus. 
Results of this study indicated that, at the 28th gestational 
day, the volume density of lamellar inclusion bodies and rough endo-
plasmic reticulum were increased in the pilocarpine-treated group, 
while glycogen was decreased compared to controls. Therefore, not 
only are there greater numbers of mature type II cells in the lungs 
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of pilocarpine-treated fetuses, as indicated by light microscopic 
morphometric analysis, but these cells contain a greater volume densi-
ty of structures involved in the production, storage and secretion 
of pulmonary surfactant. Associated with these increases is a 
decrease in the glycogen content because it is being used for the 
synthesis of surfactant phosphatidylcholine as demonstrated by Gilden 
et al. ('77) and others. 
Comparison of the stereologic results obtained from pilocarpine-
treated fetuses at the 28th gestational day with those obtained from 
controls at 29, 30 and 31 days revealed that measured components of 
the type II cells in 28-day pilocarpine-treated fetuses did not 
correspond uniformly to those of any given gestational age in controls. 
One problem in interpreting the results of this study was that the 
control alveolar type II cells were functionally mature at 29 days. 
Therefore, changes in measured cytoplasmic components occurring at 29, 
I 
' 
30 and 31 days, although indicating further maturation, woul~ not 
I 
! 
alter the viability of the fetus. 
When the stereologic data from all gestational ages are consi-
dered together (fig. 25) some trends become evident. The general 
trends observed in control fetal lung cell maturation from immature 
cuboidal cells to mature type II cells included a decrease in glyco-
gen with advancing gestational age. The lamellar inclusion bodies 
increased gradually through day 28, exhibited a large increase at day 
29 and thereafter gradually decreased. This decline late in gesta-
tion may be related to qaulitative changes of surfactant synthesis, 
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storage and release, as well as increased turn-over of surfactant 
components. Associated with these changes was a sudden increase in 
rough endoplasmic reticulum at 31 days. The amount of Golgi complex 
within control cuboidal cells remained relatively constant throughout 
the time period studied. 
It may be stated that, in general, these changes through time 
also occurred in pilocarpine-treated fetuses, but either occurred 
earlier or to a greater extent than in controls. At each day except 
the 26th gestational day, the cells of the pilocarpine-treated group 
contained a significantly greater volume density of lamellar inclusion 
bodies and significantly less glycogen. The reason for the lack of 
significant differences in these values at day 26 is unclear. However, 
it probably relates to the fact that on this day the amount of rough 
endoplasmic reticulum within the cells of the pilocarpine-treated 
group exhibited its largest increase, reaching a value nearll double 
that of controls. 
The results of the electron microscopic studies would indicate 
that repeated stimulation of the exocrine function of fetal alveolar 
epithelium with pilocarpine causes not only an increased secretion 
of surfactant in mature cells, as does a single dose (Corbet et al., 
'76), but also an increased differentiation and maturation of type II 
cells. This process is marked by an increase in the secretory appa-
ratus of these cells and by an increased utilization of glycogen 
stores for the synthesis, storage and secretion of increased amounts 
of surfactant. 
It is appropriate to mention that certain forms of fetal dis-
tress may produce changes in the fetal lung similar in some respects 
to those observed in the present study. These changes include an 
initial stimulation of secretion and a transitory acceleration of 
maturation (Balis et al., '75). However, in the reaction to stress 
or injury, these changes are usually accompanied by septal edema, 
which was not observed in the present study. Additionally, it has 
been established that following an injurious episode the type II al-
veolar epithelium of the adult (Evans et al., '75; Witschi, '76) and 
fetal (Balis~ al., '75) lung undergoes a proliferative response. 
The light microscopic morphometric results of the present study indi-
cated an increase in the number of mature type II cells in the lungs 
of pilocarpine-treated fetuses. That this is not a response to an 
injurious effect of pilocarpine is confirmed by the results of the 
scintillation autoradiographic study. These results indicated that 
l 
fewer lung cells in the pilocarpine-treated group were actively 
I 
synthesizing DNA, in preparation for cell division, when the lung 
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tissue was removed and placed in culture media containing 3H-thymidine; 
thus, they failed to incorporate the labelled precursor and therefore 
did not label the autoradiograph. 
In addition to indicating changes following injury, cell pro-
liferation has been demonstrated to be a useful criterion for judging 
maturation in the fetal lung. It has been established that cell 
proliferation in the fetal lung decreases suddenly in late gestation 
(Sorokin, '61; O'Hare and Townes, '70; Kauffman, '75). The results 
of the present study revealed a reduced proliferation of both alveolar 
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epithelial cells and interstitial cells in the lungs of pilocarpine-
treated fetuses. It may be concluded, based on these results as well 
as morphologic criteria, that pilocarpine administration resulted in 
an acceleration of differentiation and maturation of alveolar epithe-
lial cells, at the expense of proliferation. These epithelial changes 
are paralleled by decreased proliferation of mesenchymal cells, resul-
ting in thinning of septa and maturation of the lung as a whole. 
With respect to other factors thought to affect fetal lung 
maturation, it has been suggested that maternal malnutrition may have 
a stimulatory effect on surfactant secretion and lung maturation 
(Naeye et al., '74). Data obtained in a study related to the present 
one (Smith, in press) indicate that the lungs of fetuses obtained at 
the 28th gestational day from does which were fasted for 6-7 days do 
show signs of increased maturation. The type II cells of these 
fetuses, however, are characterized by many morphologically abnormal 
! 
lamellar inclusion bodies. In addition to malnutrition, incr~ased 
synthesis and secretion of surfactant was reported by Kikkawa and 
Motoyama ('73) in fetal rabbits treated with AY-9944, an inhibitor of 
cholesterol biosynthesis. This stimulation, however, was accompanied 
by retardation of the general maturation of the lung. 
Pilocarpine has been reported to be capable of stimulating the 
secretion of surfactant by type II cells in adult animals (Goldenberg 
et al., '69; Morgan and Morgan, '73). Corbet et al. ('76) have demon-
strated that direct administration of pilocarpine to fetuses results 
in a reduction of surface tension, indicating increased secretion of 
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surfactant. Morphologic evidence obtained in the single injection 
experiments of the present study suggests that single, maternally 
administered, doses of pilocarpine result in the stimulation of sur-
factant production and secretion in near-term fetal rabbit type II 
alveolar epithelial cells. The mechanism by which pilocarpine causes 
this stimulation is, however, unclear. 
Pilocarpine is a parasympathomimetic cholinergic agent which 
acts primarily at muscarinic receptors of autonomic effector cells. 
However, ganglionic effects are also observed in some cases (Koelle, 
'75). As an example, the actions of pilocarpine on the cardiovascular 
system are complex and difficult to interpret. Following administra-
tion of pilocarpine there is, as one would expect, a drop in blood 
pressure. However, if administration is preceeded by a nicotinic 
blocking agent, there is a marked increase in pressure. Atropine, a 
muscarinic blocker, abolishes both effects and the increase in pres-
! 
sure can be blocked by a S-adrenergic blocker. It is thought, that 
I 
\ 
this complex situation may occur because of an activation of excita-
tory muscarinic receptors on sympathetic ganglion cells, as well as 
adrenomedullary chromaffin cells, both of which receive sympathetic 
preganglionic fibers which employ acetylcholine as a transmitter 
substance. In addition, it is known that pilocarpine has various 
central nervous system effects, ranging from evocation of the corti-
cal arousal system, to autonomic and somatic motor effects suggesting 
activation of paraventricular hypothalamic nuclei. The ~ommon bond 
which links the effects of pilocarpine is the ability of atropine to 
completely block them all, which would indicate that they are all due 
to activation of muscarinic binding sites. 
Hung et al. ('72) demonstrated axonal endings of an autonomic 
nature in close proximity to type II pneumocytes and concluded that 
( 
these provided a morphologic connection between the autonomic nervous 
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system and surfactant secretion. It has been demontrated that surfac-
tant secretion is deleteriously affected by vagotomy (Goldenberg 
et al., '67); conversely, stimulation of the vagus results in increas-
ed surfactant secretion (Oyarzun and Clements, '77). Judging by this, 
it is logical to conclude that the nerve endings observed by Hung and 
co-workers are of vagal origin; thus, the type II pneumocytes would 
possess muscarinic receptor sites. 
In a pharmacologic study, Corbet et al. ('77) theorized that the 
action of pilocarpine on surfactant secretion may be due to sympathe-
tic stimulation. He suggested that the nerve endings presenJ in the 
I 
lung alveolar wall are of sympathetic origin and that the typ,1e II cells 
possessed S-adrenergic receptors. However, studies by Beckman et al. 
('71) and Bergren and Beckman ('76) suggested that sympathetic. stim-
ulation causes a decrease in surfactant activity. The very fact that 
vagal stimulation causes increased surfactant secretion makes it dif-
ficult to accept sympathetic, S-adrenergic, innervation of type II 
pneumocytes, as Corbet proposed. It may be speculated that pilocar-
pine, due to its action at the adrenal medullary or ganglionic recep-
tors, is, in fact, acting through an entirely different mechanism than 
that activated through vagal efferent stimulation. However, 
oxotremorine, a synthetic analog of muscarine which has none of pilo-
carpine's predilection for these sites, has also been demonstrated to 
stimulate alveolar type II cells (Abdeblatif and Hollingsworth, '77). 
As may be inferred from this discussion, the question of whether the 
effect of pilocarpine is due to parasympathetic or sympathetic acti-
vation remains unresolved. However, it seems highly probable that 
its action is related to the existence of an autonomic control mecha-
nism for surfactant secretion. 
The findings of the present study indicate that repeated pilo-
carpine stimulation of the fetal rabbit surfactant system results in 
increased maturation of the type II epithelial cells of the alveolus, 
and the lung as a whole. The results have much in common with those 
obtained through glucocorticoid administration (Kikkawa et al., '71, 
and others) and the protocol of the present study does not absolutely 
rule out the possibility of endogenous corticosteroid influence. The 
I 
I 
I 
same, however, may be said of any study, to date, which has a:,ttempted 
to pharmacologically enhance fetal lung maturation. The results of 
the single injection experiments of the present study, as well as the 
results of Pysher ('77) employing fetal lung in culture which was 
thus obviously separated from corticosteroid influence, have demon-
strated that fetal lung is responsive to pilocarpine. Furthermore, 
in the present study stereologic analysis revealed maturational 
changes 24 hours after a single pilocarpine injection at the 24th 
gestational day while most studies using corticosteroids cite results 
48-72 hours after multiple injections. 
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It is probable that normal lung maturation is controlled through 
many inter-acting mechanisms and systems, since it is possible, exper-
imentally, to influence lung maturation through a variety of means. 
Although the natural role of the autonomic nervous system in the 
developing lung is unknown, the results of the present study indicate 
that the maturation of the fetal lung can be influenced through auto-
nomic manipulation. Respiratory distress syndrome of the newborn has 
been linked to immaturity of the surfactant system of the lung. The 
results of this study contribute to the knowledge available concerning 
factors influencing or controlling the maturation of the fetal lung 
and its surfactant system, knowledge essential to promote development 
of rational modes of therapy. 
SUHHARY 
Pilocarpine HCl, a parasympathomimetic drug, was administered 
to pregnant white rabbits at various times late in gestation. Morpho-
logic studies indicated that this resulted in a stimulation 1of surfac-
taut synthesis and secretion. The same drug was then administered in 
a daily subcutaneous injection of 5 mg/kg on day 24 through day 27 of 
gestation. Fetuses from these animals and from saline injected 
controls were obtained by cesarean section on day 28 of gestation, 
term being 31 days in the rabbit. Histologic examination revealed 
thinner alveolar septa, and in sections stained with periodic acid-
Schiff (PAS), a. decrease in PAS positive material in the lungs of 
pilocarpine-treated fetuses when compared with controls. Morphometric 
evaluation indicated a significant increase in the number of mature 
type II cells in the alveolar epithelium of pilocarpine-treated 
fetuses, both per unit area and per 1,000 lung cells of any J,ind. 
I 
I 
Scintillation autoradiography using 1 ~m thick methacrylate sections 
of fetal lung, from both groups, which was incubated with 3H-thymidine 
in vitro, revealed a significant decrease in the labelled cell indices 
of alveolar epithelial cells, as well as interstitial cells, in the 
lungg of pilocarpine-treated fet4ses. 
Electron microscopic studies revealed that the alveoli of the 
pilocarpine-treated group were lined by epithelial cells at a more 
advanced stage of maturation than those of controls. Type I cells in 
the pilocarpine-treated group were consistently well differentiated, 
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forming thin blood-air barriers. Ultrastructural findings in type II 
cells of this group included a substantial reduction in glycogen con-
tent, well developed or dilated rough endoplasmic reticulum and a 
significant increase (as determined by morphometric analysis) in the 
number and size of lamellar inclusion bodies, as well as the number 
of multivesicular bodies. Electron microscopic stereology indicated 
a significant increase in the cytoplasmic volume density of lamellar 
inclusion bodies, rough endoplasmic reticulum and Golgi complex in the 
pilocarpine-treated group while indicating a significant decrease in 
glycogen content. This observation of decreased glycogen was substan-
tiated by the biochemical determination of glycogen content in the 
fetal lungs. 
Stereologic analysis of type II cells from fetuses treated with 
piloc~rpine as above but maintained, after cessation of drug admin-
istration at the 27th day, till the 31st day, showed no deleterious 
\ 
effects of pilocarpine treatment; in fact, this study indicat~ed a 
I 
sustained stimulation of surfactant sythesis and storage. Similar 
studies of type II cells from fetuses treated with pilocarpine for 
1, 2 or 3 days and obtained at day 25, 26 and 27 of gestation respec-
tively, yielded a time-sequence of the effect of pilocarpine which 
indicated that maturational changes were evident as early as the 25th 
gestational day. 
The findings of this study provide evidence that maternal 
administration of pilocarpine results in accelerated differentiation 
and maturation of fetal type II alveolar epithelial cells from immature 
cuboidal cells, at the expense of proliferation. This results in 
an increased activity of the type II cells in the synthesis, storage 
and secretion of pulmonary surfactant. These changes are accompanied 
by decreased proliferation of mesenchymal cells and increased matura-
tion of type I epithelial cells, leading to thinner alveolar' septa 
and blood-air barriers and, therefore, increased maturation of the 
lung as a whole. 
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PLATE I 
Figure 1. Light micrographs of paraffin embedded lung from 
a 28-day fetus injected with saline in utero. 
Sections are stained with periodic acid-Schiff 
(PAS) and thus dark area represent PAS-positive 
material: la; Bronchiolar cells (B) contain dark 
staining representing PAS-positive glycogen. Septa 
are relatively thin with far less PAS-positive 
staining than similar lungs of non-operated con-
trols (compare with figure 9a) X 270. lb; Higher 
magnification of same lung. While bronchiolar 
cells (B) contain abundant darkly stained! glycogen 
many alveolar epithelial cells contain little or 
none (arrows). Contrast this with figure\ 9b. 
X 1060. 
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PLATE II 
Figure 2. Light micrographs of paraffin embedded lung from 
a 28-day fetus injected with pilocarpine in utero. 
Sections are stained, photographed and enlarged 
exactly as those of figures 1, 9 and 10. 2a; 
Bronchiolar cells (B) contain PAS-positive stain-
ing. This lung is much like those of the controls 
illustrated in figure 1, with the exception that 
following pilocarpine injection, the lungs contain 
even less PAS-positive glycogen. Note surfactant 
material (S) in alveolar space. X 270. 2b; Higher 
magnification of the same lung. Arrows indicate 
alveolar epithelial cells containing little or no 
glycogen. X 1060. 
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PLATE III 
Figure 3. Electron micrograph of a type II cell from the 
lung of a 28-day fetus injected with saline in 
utero. Lamellar inclusion bodies (L) are rela-
tively numerous while glycogen (G) is scant. 
Compare with figure 17, which shows a similar cell 
from a non-operated control. R, rough endoplasmic 
reticulum; Go, Golgi complex; A, alveolar space. 
X 15,000. 
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PLATE IV 
Figure 4. Electron micrograph of a type II cell from a fetus 
injected with pilocarpine in ute~o. Note large 
lamellar inclusion bodies (L) aggregated at the 
apex of the cell with one (arrow) apparently about 
to be discharged into the alveolar space (A). 
X 15,000. 
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P~EV 
Figure 5. Electron micrograph of a typical adult rabbit type 
II alveolar epithelial cell. Note the vacuolar 
appearance of lamellar inclusion bodies (L) and 
inconspicuous rough endoplasmic reticulum (R). 
Go, Golgi complex; M, Mitochondria; A, Alveolar 
space. X 21,000. 
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PLATE VI 
Figure 6. Electrotl micrograph of a type II cell from an 
adult rabbit which received a single injection of 
pilocarpine (150 mg/kg) two hours prior to sac-
rifice. Large lamellar inclusion bodies (L) are 
located apically and rough endoplasmic reticulum 
(R) is dilated. A, Alveolar space. X 31,000 
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PLATE VII 
Figure 7. Electron micrograph of a type II cell from the 
lung of a 29-day control fetal rabbit obtained 
early in the project. Note greater development of 
lamellae within the lamellar inclusion bodies (L) 
when compared to those of the adult. Glycogen (G), 
which is virtually absent in adult type II cells, 
is also present within this cell. A, Alveolar 
space; M, mitochondria; Go, Golgi complex. 
X 16,800. 

PLATE VIII 
Figure 8. Electron micrograph of type II epithelial cells 
from a 29-day fetus whose mother had received 40 
mg/kg pilocarpine six hours earlier. Rough endo-
plasmic reticulum (R) is dilated, glycogen is 
111 
very scant and lamellar inclusion bodies (L) are 
apically located with one in each cell being ap-
parently secreted (arrows) into the alveolar space 
(A). X 21,000. 
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PLATE IX 
Figure 9. Light micrographs of paraffin embedded lung from 
a 28-day control fetus. 9a; Note relative thick-
ness of alveolar septa and heavy PAS staining in 
bronchiolar (B), septal and alveolar epithelial 
cells. X 270. 9b; Higher magnification of same. 
Alveolar epithelial cells (arrows) contain large 
amounts of PAS-positive glycogen. X 1060. 
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PLATE X 
Figure 10. Light micrographs of paraffin embedded lung from 
a pilocarpine-treated 28-day fetus. lOa; Alveolar 
septa are, for the most part, thinner than cont-
rols while PAS-positive staining is negligible. 
X 270. lOb; Higher magnification of same. Al-
veolar epithelial cells (arrows) contain little 
or no PAS-positive glycogen X 1060. 

PLATE XI 
Figure 11. Light micrographs of 1 ~m thick toluidine blue 
stained sections of 28-day fetal lungs. lla; 
114 
Low power of control. Note thick alveolar septa 
and relatively sparse blood-air barriers. X 550. 
llb; Higher magnification of same. A mature type 
II cell is shown at the arrow. Portions of the 
alveolar space are lined by immature cuboidal 
cells (c) which contain abundant darkly stained 
glycogen. X 2,200. llc; Low power of pilocar-
pine treated fetal lung. Note· thinner alveolar 
septa and better development of blood-a~r bar-
riers. X 550. lld; Higher magnification of same. 
I 
Mature type II cells containing intensel~ stained 
lamellar inclusion bodies are noted at the arrows. 
X 2,200. 
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Figure 12. The histogram on the left illustrates the numer-
ical distribution of mature, or well differentia-
ted type II alveolar epithelial cells per unit 
area (0.035 mm2) of a 1 ~m thick section of fetal 
lung from the upper and lower lobes of each group. 
On the right is a similar histogram of the number 
of mature type II cells per 1,000 lung parenchy-
mal cells. P, pilocarpine-treated; C, control. 
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PLATE XII 
Figure 13. Survey electron micrograph of a 28-day control 
fetal lung. Type II cells (II) contain large 
amounts of glycogen and few lamellar bodies. 
Blood-air barrier (BAB) is very thick and the 
epithelial component contains a heavy accumulation 
of glycogen. A, alveolar space; RBC, red blood 
cell in alveolar capillary lumen; I, interstitial 
cell. X 6,000 
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PLATE XIII 
Figure 14. Survey electron micrograph illustrating alveolar 
epithelial cells of a 28-day pilocarpine-treated 
fetus. Type II cells contain little glycogen and 
relatively numerous lamellar inclusion bodies. 
Blood-air barriers (BAB) are well developed and 
thin. E, endothelial cell of capillary; C, capil-
lary lumen; A, alveolar space. X 6,000. 

Figure 15. 
Figure 16. 
' 
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PLATE XIV 
Type I alveolar epithelial cell from a 28-day 
control rabbit fetus. Nucleus (N) is surrounded 
by abundant cytoplasm containing much glycogen 
(G). Cell extension is thin on the right and 
forms blood-air barrier over capillary (C). On 
the left side the cell extension is thick, con-
tains mitochondria (M) and rough endoplasmic re-
ticulum (R) and overlies a capillary endothelial 
cell (E). A, alveolar space. X 14,000. 
Type I cell of a 28-day pilocarpine-treated fetus. 
Nucleus (N) is surrounded by a thin rim of cyto-
plasm containing virtually no glycogen. I Cell 
extensions are attenuated to form blood-air bar-
riers over capillary lumens (C). Note surfactant 
material (S) in alveolar space. X 10,000. 
\ 
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PLATE XV 
Figure 17. Type II cell of a 28-day control rabbit fetus. 
The cytoplasm contains abundant glycogen (G) and 
few lamellar inclusion bodies (L), usually con-
taining sparse lamellae. A, alveolar space. 
X 13,000. 
Figure 18. Type II cell of a 28-day pilocarpine-treated 
fetus. Glycogen is virtually absent while lamel-
lar inclusion bodies (L) are numerous and show 
well developed, darkly staining lamellae. Notice 
lamellar body apparently in the process 1of being 
secreted (S) into the alveolar space (A)!,, as well 
as a multivesicular body (MV) and well developed 
cisternae of rough endoplasmic reticulum' (R). 
X 10,500. 
® 
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PLATE XVI 
Figure 19. Portion of a 28-day control type II cell. Note 
glycogen (G) and indistinct lamellae of inclusion 
body (L). M, mitochondrion; N, nucleus. 
X 30,000. 
Figure 20. Portion of a type II cell from a pilocarpine-
treated fetus. Glycogen (G), when present, is 
usually found in association with surfactant ma-
terial (L). Note transitional form of inclusion 
body (T). M, mitochondrian. X 33~000. 

121 
( 
PLATE XVII 
Figure 21. Light micrograph of a 1 ~m thick plastic section 
of a control fetal lung illustrating the label-
ling obtained through scintillation autoradiogra-
phy. Labelled alveolar epithelial cells (short 
arrows) and interstitial cells (long arrows) are 
readily identified. X 1,380. 
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Figure 22. Histogram illustrating the results of the 3H-
thymidine incorporation study on the alveolar 
epithelium and lung interstitium of pilocarpine-
treated (P) and control (C) rabbit fetuses. Re-
sults are expressed as labelled cells per 1,000 
cells and the small lines represent the standard 
error of the mean. 
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PLATE XVIII 
Figure 23. Electron micrograph of a type II cell from a 31-
day control fetus. Glycogen (G) is, by now, 
scarce and lamellar inclusion bodies (L) well 
developed. A, alveolar space. X 10,500. 
Figure 24. Electron micrograph of a type II cell from a 31-
day fetus which was treated with pilocarpine on 
days 24 through 27 of gestation. No evidence 
of damage is apparent. A, alveolar space. 
X 14,000. 
A 
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Figure 25. Histograms illustrating the results of the elec-
tron microscopic stereologic analysis of various 
cell components involved in the synthesis and 
secretion of surfactant. Results are expressed 
as percentages of cytoplasmic volume and the small 
lines represent the standard error of the mean. 
Numbers at the bottom of each graph represent 
gestational age. C, control; P, pilocarpine-
treated. 1 
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PLATE XIX 
Figure 26. Electron micrograph of an immature cuboidal cell 
lining the alveolus of a 25-day control fetus. 
Note lack of lamellar inclusion bodies and abun-
dant glycogen (G). A, alveolar space. X 13,000. 
Figure 27. Electron micrograph of an immature type II cell 
from a 25-day pilocarpine-treated fetus. Glyco-
gen (G) is less abundant than in controls, while 
the secretory apparatus is more apparent. Note 
immature form of inclusion body (IF). Go, Golgi 
complex; A, alveolar space. X 14,000. \ 

PLATE XX 
Figure 28. Electron micrograph of an immature type II cell 
from a 28-day control fetus. Glycogen (G) has 
decreased from 25-day levels. Note immature 
forms of inclusion bodies (IF). A, alveolar 
space. X 13,500 
Figure 29. Electron micrograph of an immature type II cell 
from a 26-day pilocarpine-treated fetus. These 
cells differed little from similar cells of 25-
1 
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days. G, glycogen; Go, Golgi complex; Ir, imma-
ture inclusion body; A, alveolar space. • X 13,500 
\ 
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PLATE XXI 
Figure 30. Electron micrograph of a type II cell from a 27-
day control fetus. Glycogen (G) is fairly abun-
dant. Note intermediate form of lamellar inclu-
sion body (arrow) as well as mature forms (L). 
X 13,000. 
Figure 31. Electron micrograph of a type II cell from a 27-
day pilocarpine-treated fetus. Lamellar inclu-
sion bodies (L) are mature and relatively numer-
ous while glycogen (G) is becoming scant,. Note 
dilated rough endoplasmic reticulum (R).I A, 
alveolar space. X 11,000. 
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